Document:

EX-4.4

Exhibit 4.4

CHINA HYDROELECTRIC CORPORATION

AMENDED AND RESTATED SHAREHOLDERS AGREEMENT

 

 

AMENDED AND RESTATED SHAREHOLDERS AGREEMENT

     THIS AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this “Agreement”) is entered into as of
October 27, 2009 (the “Effective Date”), by and among China Hydroelectric Corporation, a company duly
incorporated and validly existing under the Laws of the Cayman Islands (the “Company”), the
investors listed on Exhibit A(i) attached hereto (each, a “Series C Investor,” and
collectively, the “Series C Investors”), the entities listed on Exhibit A(ii) attached
hereto (the “Ordinary Shareholders”), the entities listed on Exhibit A(iii) attached hereto
(the “Series A Investors”), the entities listed on Exhibit A(iv) attached hereto (the
“Series B Investors”), the individuals listed on Exhibit A(v) attached hereto (the
“Founders”), and the entities listed on Exhibit A(vi) attached hereto (the “Warrant
Holders”). The Company, the Series C Investors, the Ordinary Shareholders, the Series A Investors,
the Series B Investors, the Founders and the Warrant Holders are referred to herein collectively as
“Parties” and individually as a “Party.”

RECITALS

	A.	 	The Parties other than the Series C Investors entered into an Amended and Restated
Shareholders Agreement dated as of July 24, 2008 (the “Original Shareholders Agreement”);
	 
	B.	 	The Company, each other member of the Company Group (as defined below) and the Series C
Investors have entered into a Series C Preferred Share Purchase Agreement dated as of even
date herewith (the “Series C Share Purchase Agreement”).
	 
	C.	 	It is a condition precedent under the Series C Share Purchase Agreement that the Original
Shareholders Agreement be amended and restated in accordance with the terms and conditions
hereof.
	 
	D.	 	The parties desire to enter into this Agreement and to accept the rights, covenants and
obligations hereof.

WITNESSETH

     NOW, THEREFORE, in consideration of the premises set forth above, the mutual promises and
covenants set forth herein and other good and valuable consideration, the Parties agree as follows:

1. Interpretation.

     1.1 Definitions. The following terms shall have the meanings ascribed to them below:

     “As Adjusted” means as appropriately adjusted for any subsequent bonus issue, share
split, consolidation, subdivision, reclassification, recapitalization or similar
arrangement.

     “Accepting Shareholders” has the meaning set forth in Section 9.1 hereof.

     “Affiliate” means, with respect to a Person, any other Person that, directly or
indirectly, Controls, is Controlled by or is under common Control with such Person.

					
	 	 	 	 	 
	 
	 	1
	 	Shareholders Agreement

 

 

     “Agreement” has the meaning set forth in the Preamble of this Agreement.

     “Annual Capital Budget” has the meaning set forth in Section 12.9 hereof.

     “Applicable Securities Laws” means (i) with respect to any offering of securities in
the United States, or any related act or omission within that jurisdiction, the securities
Law of the United States, including the Exchange Act and the Securities Act, and any
applicable securities Laws of any state of the United States, and (ii) with respect to any
offering of securities in any jurisdiction other than the United States, or any related act
or omission in that jurisdiction, the applicable securities Laws of that jurisdiction.

     “Arbitration Notice” has the meaning set forth in Section 15.2(ii) hereof.

     “Audit Committee” has the meaning set forth in Section 11.3 hereof.

     “Board” or “Board of Directors” means the board of directors of the Company.

     “Board Observer” has the meaning set forth in Section 11.8 hereof.

     “CFC” means a controlled foreign corporation as defined in the Code.

     “Change-of-Control Event” means (i) any consolidation, amalgamation, scheme of
arrangement or merger of the Company with or into any other person or any other corporate
reorganization in which the members of the Company immediately prior to such consolidation,
amalgamation, merger, scheme of arrangement or reorganization own less than a majority of
the Company’s voting power immediately after such consolidation, merger, amalgamation,
scheme of arrangement or reorganization, or any transaction or series of related
transactions to which the Company is a party in which at least a majority of the Company’s
voting power is transferred; or (ii) a sale, transfer, lease or other disposition of all or
substantially all of the assets of the Company or of the other members of the Company Group,
taken as a whole (or any series of related transactions resulting in such sale, transfer, or
lease of all or substantially all of the assets of the Company or of the other members of
the Company Group, taken as a whole).

     “Closing” has the meaning set forth in the Series C Share Purchase Agreement.

     “Code” has the meaning set forth in Section 10.5(ii) hereof.

     “Commission” means (i) with respect to any offering of securities in the United States,
the Securities and Exchange Commission of the United States or any other federal agency at
the time administering the Securities Act, and (ii) with respect to any offering of
securities in a jurisdiction other than the United States, the regulatory body of the
jurisdiction with authority to supervise and regulate the offering and sale of securities in
that jurisdiction.

     “Company” has the meaning set forth in the Preamble of this Agreement.

     “Company Group” has the meaning set forth in the Series C Share Purchase Agreement.

2

 

     “Compensation Committee” has the meaning set forth in Section 11.3 hereof.

     “Control” of a given Person means the power or authority, whether exercised or not, to
direct the business, management and policies of such Person, directly or indirectly, whether
through the ownership of voting securities, by contract or otherwise, which power or
authority shall conclusively be presumed to exist upon possession of beneficial ownership or
power to direct the vote of more than fifty percent (50%) of the votes entitled to be cast
at a meeting of the members or shareholders of such Person or power to control the
composition of a majority of the board of directors of such Person; the term “Controlled”
has the meaning correlative to the foregoing.

     “Dispute” has the meaning set forth in Section 15.2(i) hereof

     “Effective Date” has the meaning set forth in Preamble of this Agreement.

     “Environmental Law” has the meaning set forth in the Series C Share Purchase Agreement.

     “Equity Securities” means any Ordinary Shares and/or Ordinary Share Equivalents of the
Company.

     “ESOP” has the meaning set forth in the Memorandum and Articles.

     “Exchange Act” means the United States Securities Exchange Act of 1934, as amended.

     “Exercising Holder” has the meaning set forth in Section 9.4 hereof.

     “FCPA” means the United States Foreign Corrupt Practices Act of 1977, as amended.

     “Fifth Anniversary” has the meaning set forth in Section 11.1(ii) hereof.

     “Founders” has the meaning set forth in the Preamble of this Agreement.

     “Form F-3” means Form F-3 promulgated by the Commission under the Securities Act or any
successor form or substantially similar form then in effect.

     “Form S-3” means Form S-3 promulgated by the Commission under the Securities Act or any
successor form or substantially similar form then in effect.

     “Governmental Authority” means any nation or government or any nation, province or
state or any other political subdivision thereof; any entity, authority or body exercising
executive, legislative, judicial, regulatory or administrative functions of or pertaining to
government, including any government authority, agency, department, board, commission or
instrumentality of the PRC or any other country, or any political subdivision thereof, any
court, tribunal or arbitrator, and any self-regulatory organization.

     “HKIAC” has the meaning set forth in Section 15.2(iii) hereof.

3

 

     “Holders” means the Series A Registrable Securities Holders, the Series B Registrable
Securities Holders and the Series C Registrable Securities Holders.

     “Initiating Holders” means, with respect to a request duly made under Section
2.1 or Section 2.2 to Register any Registrable Securities, the Holders
initiating such request.

     “Investors” means the Series A Investors, the Series B Investors and the Series C
Investors.

     “IPO” means the first firmly underwritten registered public offering by the Company of
its Ordinary Shares pursuant to a Registration Statement that is filed with and declared
effective by either the Commission under the Securities Act or another Governmental
Authority for a public offering in a jurisdiction other than the United States.

     “Key Employee” has the meaning set forth in the Memorandum and Articles.

     “Law” means any constitutional provision, statute or other law, rule, regulation,
official policy or interpretation of any Governmental Authority and any injunction,
judgment, order, ruling, assessment or writ issued by any Governmental Authority.

     “Liquidation Event” has the meaning set forth in Section 14.2 hereof.

     “Majority-in-Interest” means an interest in the voting securities of a Person or
Persons that exceeds 50% of such voting securities of such Person or Persons.

     “Memorandum and Articles” has the meaning set forth in the Series C Share Purchase
Agreement.

     “New Securities” means, subject to the terms of Section 8 hereof, any newly
issued Equity Securities of the Company, except for (i) any Ordinary Share issued or
issuable to employees, officers, consultants or directors of the Company, as approved by the
Board including all Preferred Directors (except that in the event any holder or holders of
Preferred Shares elect not to designate a Preferred Director such holder(s) have the right
to designate, then the approval of any Board Observer designated pursuant to Section
11.8(i), if any, shall be required), if any, on exercise of grants made in accordance
with the ESOP with respect to Ordinary Shares and granted to employees, consultants or
directors of the Company (other than options held as of the date hereof), so long as the
aggregate number of such Ordinary Shares issued does not exceed 7.5% of the number of
Ordinary Shares outstanding on a fully diluted basis; (ii) securities issued upon conversion
of the Preferred Shares or exercise of any properly issued and outstanding notes, warrants
or options; (iii) securities issued in connection with a bona fide acquisition of another
business; (iv) securities issued in an IPO; (v) securities issued in connection with any
share split, share dividend, combination, recapitalization or similar transaction of the
Company; (vi) securities issued pursuant to the Series C Share Purchase Agreement; or (vii)
any other issuance of Equity Securities whereby each Investor gives a written waiver of its
rights under this Agreement at its sole discretion.

     “Ordinary Directors” has the meaning set forth in Section 11.1(i) hereof

4

 

     “Ordinary Shares” means the Company’s ordinary shares, par value US$0.001 per share.

     “Ordinary Share Equivalents” means warrants, options and rights exercisable for
Ordinary Shares or securities convertible into or exchangeable for Ordinary Shares,
including, without limitation, the Series A Preferred Shares, the Series B Preferred Shares
and the Series C Preferred Shares.

     “Ordinary Shareholders” has the meaning set forth in the Preamble of this Agreement.

     “Original Preferred Issue Price” means US$1,000 with respect to each of the Series A
Preferred Shares, the Series B Preferred Shares and the Series C Preferred Shares.

     “Original Shareholders Agreement” has the meaning set forth in the Recitals hereof.

     “Party” or “Parties” has the meaning set forth in the Preamble of this Agreement.

     “Person” means any individual, corporation, partnership, limited partnership,
proprietorship, association, limited liability company, firm, trust, estate or other
enterprise or entity.

     “PFIC” has the meaning set forth in Section 10.5(ii) hereof.

     “PRC” means the People’s Republic of China, but solely for the purposes of this
Agreement, excluding the Hong Kong Special Administrative Region, the Macau Special
Administrative Region and the islands of Taiwan.

     “PRC Resident Enterprise” has the meaning set forth in Section 10.6(i) hereof.

     “Preferred Director” has the meaning set forth in Section 11.1(i) hereof.

     “Preferred Shares” means the Series A Preferred Shares, the Series B Preferred Shares
and the Series C Preferred Shares.

     “Preferred Share Holder” has the meaning set forth in Section 8.1 hereof.

     “Preferred Share Holder Notice” has the meaning set forth in Section 8.2
hereof.

     “Preferred Share Holder Participation Period” has the meaning set forth in Section
8.2 hereof.

     “Principal Tribunal” has the meaning set forth in Section 15.2(viii)(a) hereof.

     “Public Official” has the meaning set forth in the Series C Share Purchase Agreement.

5

 

     “Qualified IPO” has the meaning given to such term in the Memorandum and Articles.

     “Registrable Securities” means the Series A Registrable Securities, the Series B
Registrable Securities and the Series C Registrable Securities.

     “Registration” means a registration effected by preparing and filing a Registration
Statement and the declaration or ordering of the effectiveness of that Registration
Statement; and the terms “Register” and “Registered” have meanings concomitant with the
foregoing.

     “Registration Statement” means a registration statement prepared on Form F-1, F-2, F-3,
S-1, S-2 or S-3 under the Securities Act (including, without limitation, Rule 415 under the
Securities Act), or on any comparable form in connection with registration in a jurisdiction
other than the United States.

     “Remaining Shareholders” has the meaning set forth in Section 9.1 hereof.

     “Remaining Securities” has the meaning set forth in Section 8.4 hereof.

     “Representatives” has the meaning set forth in Section 12.4 hereof.

     “Sale of the Company” means either a Share Sale or a Liquidation Event.

     “Section 951 Inclusion” has the meaning set forth in Section 10.5(v) hereof.

     “Securities Act” means the United States Securities Act of 1933, as amended.

     “Series A and Series B Lead Investor” means CPI Ballpark Investments Ltd. or its
successor.

     “Series A Investors” has the meaning set forth in the Preamble of this Agreement.

     “Series A Preferred Shares” means the Series A Preferred Shares, par value US$0.001 per
share, issued by the Company pursuant to the Series A Share Purchase Agreement, the rights,
privileges and preferences of which are specified in the Memorandum and Articles.

     “Series A Registrable Securities” means (i) the Ordinary Shares issuable or issued upon
conversion of the Series A Preferred Shares, (ii) any Ordinary Shares owned or hereafter
acquired by the Series A Investors and (iii) any Ordinary Shares of the Company issued as a
dividend or other distribution with respect to, in exchange for, or in replacement of, the shares referenced in (i) and (ii) herein, excluding in all cases, however, any of the
foregoing sold by a Person in a transaction other than an assignment pursuant to Section
13. For purposes of this Agreement, (a) Series A Registrable Securities shall cease to
be Registrable Securities when a Registration Statement covering the resale of such Series A
Registrable Securities has been declared effective under the Securities Act by the
Commission whether or not such Series A Registrable Securities have been disposed of
pursuant to such effective Registration Statement and (b) the Series A Registrable
Securities shall not be deemed to be Registrable Securities at any time when the entire
amount of such Series A Registrable

6

 

Securities proposed to be sold by their Holder in a single sale are or, in the opinion
of counsel satisfactory to the Company and such Holder, each in their reasonable judgment,
may be, so distributed to the public pursuant to Rule 144 (or any successor provision then
in effect) under the Securities Act in any three (3) month period or any such Series A
Registrable Securities have been sold in a sale made pursuant to Rule 144 of the Securities
Act.

     “Series A Registrable Securities Holders” means the holders of the Series A Registrable
Securities who are parties to this Agreement from time to time, and their permitted
transferees that become parties to this Agreement from time to time.

     “Series A Share Purchase Agreement” means the Preferred Share Purchase Agreement
entered into by and among the Company, each other then-existing member of the Company Group,
the Series A Investors and the Founders on December 31, 2007 for the purchase of the Series
A Preferred Shares.

     “Series B Investors” has the meaning set forth in the Preamble of this Agreement.

     “Series B Preferred Shares” means the Series B Preferred Shares, par value US$0.001
per share, issued by the Company pursuant to the Series B Share Purchase Agreement, the
rights, privileges and preferences of which are specified in the Memorandum and Articles.

     “Series B Registrable Securities” means (i) the Ordinary Shares issuable or issued upon
conversion of the Series B Preferred Shares, (ii) any Ordinary Shares owned or hereafter
acquired by the Series B Investors and (iii) any Ordinary Shares of the Company issued as a
dividend or other distribution with respect to, in exchange for, or in replacement of, the
shares referenced in (i) and (ii) herein, excluding in all cases, however, any of the
foregoing sold by a Person in a transaction other than an assignment pursuant to Section
13. For purposes of this Agreement, (a) Series B Registrable Securities shall cease to
be Registrable Securities when a Registration Statement covering such Series B Registrable
Securities has been declared effective under the Securities Act by the Commission whether or
not such Series B Registrable Securities have been disposed of pursuant to such effective
Registration Statement and (b) the Series B Registrable Securities shall not be deemed to be
Registrable Securities at any time when the entire amount of such Series B Registrable
Securities proposed to be sold by their Holder in a single sale are or, in the opinion of
counsel satisfactory to the Company and such Holder, each in their reasonable judgment, may
be, so distributed to the public pursuant to Rule 144 (or any successor provision then in
effect) under the Securities Act in any three (3) month period or any such Series B
Registrable Securities have been sold in a sale made pursuant to Rule 144 of the Securities
Act.

     “Series B Registrable Securities Holders” means the holders of the Series B Registrable
Securities who are parties to this Agreement from time to time, and their permitted
transferees that become parties to this Agreement from time to time.

     “Series B Share Purchase Agreement” means the Preferred Share Purchase Agreement
entered into among the Company, each other then-existing member of the Company Group, the
Series B Investors and the Founders on July 24, 2008 for the purchase of the Series B
Preferred Shares.

7

 

     “Series C Investors” has the meaning set forth in the Preamble hereof.

     “Series C Preferred Shares” means the Series C Preferred Shares, par value US$0.001
per share, issued by the Company pursuant to the Series C Share Purchase Agreement, the
rights, privileges and preferences of which are specified in this Agreement and the
Memorandum and Articles.

     “Series C Registrable Securities” means (i) the Ordinary Shares issuable or issued upon
conversion of the Series C Preferred Shares, (ii) any Ordinary Shares owned or hereafter
acquired by the Series C Investors and (iii) any Ordinary Shares of the Company issued as a
dividend or other distribution with respect to, in exchange for, or in replacement of, the
shares referenced in (i) and (ii) herein, excluding in all cases, however, any of the
foregoing sold by a Person in a transaction other than an assignment pursuant to Section
13. For purposes of this Agreement, (a) Series C Registrable Securities shall cease to
be Registrable Securities when a Registration Statement covering such Series C Registrable
Securities has been declared effective under the Securities Act by the Commission whether or
not such Series C Registrable Securities have been disposed of pursuant to such effective
Registration Statement and (b) the Series C Registrable Securities shall not be deemed to be
Registrable Securities at any time when the entire amount of such Series C Registrable
Securities proposed to be sold by their Holder in a single sale are or, in the opinion of
counsel satisfactory to the Company and such Holder, each in their reasonable judgment, may
be, so distributed to the public pursuant to Rule 144 (or any successor provision then in
effect) under the Securities Act in any three (3) month period or any such Series C
Registrable Securities have been sold in a sale made pursuant to Rule 144 of the Securities
Act.

     “Series C Registrable Securities Holders” means the holders of the Series C Registrable
Securities who are parties to this Agreement from time to time, and their permitted
transferees that become parties to this Agreement from time to time.

     “Series C Share Purchase Agreement” has the meaning set forth in the Recitals hereof.

     “Shares” means the Ordinary Shares and Preferred Shares.

     “Shareholder” means any holder of Preferred Shares and/or Ordinary Shares that is party
to this Agreement.

     “Share Sale” means a transaction or series of related transactions in which a Person,
or a group of related Persons, acquires Shares representing more than fifty percent (50%) of
the outstanding voting power of the Company.

     “Subsidiary” means, with respect to any specified Person, any other Person Controlled
by the specified Person, directly or indirectly, whether through contractual arrangements or
through ownership of equity securities, voting power or registered capital.

     “Tax” or “Taxes” means all tax imposed by any Governmental Authority in the Cayman
Islands, the PRC or elsewhere, including national, provincial, local, or foreign taxes and
other taxes on income, estimated income, alternative or add-on minimum, gross receipts,
profits, withholding (e.g. employees’ individual income taxes), business,

8

 

license, occupation, stamp, premium, value added, consumption, utility, franchise,
service, personal and real property (including special assessments or charges), sales, use,
transfer, gains, excise, severance, environmental, unclaimed property, employment,
unemployment, payroll, withholding, disability, social security, minimum tax, capital stock,
registration, or any other tax, custom duty, ad valorem levy, governmental fee, or other
like assessment or charge of any kind, together with any interest or any penalty, addition
to tax, or additional amount, whether disputed or not, and including any liability for the
Taxes of any person as a transferee, successor, or agent, by contract, or otherwise.

     “Taxable CFC Shareholder” has the meaning set forth in Section 10.5(v) hereof.

     “U.S.” means the United States of America.

     “U.S. GAAP” means generally accepted accounting principles in the United States,
applied on a consistent basis.

     “U.S. Shareholder” has the meaning set forth in Section 10.5(v) hereof.

     “U.S. Holder” means a holder of Preferred Shares that is a U.S. Person, or that is
owned in whole or in part, directly or indirectly, by U.S. Persons, within the meaning of
Section 7701(a)(30) of the Code.

     “Violation” has the meaning set forth in Section 6.1 hereof.

     “Warrant Holders” has the meaning set forth in the Preamble of this Agreement.

     1.2 Interpretation. For all purposes of this Agreement, except as otherwise expressly
provided, (i) the terms defined in this Section 1 shall have the meanings assigned to them
in this Section 1 and include the plural as well as the singular, (ii) all accounting terms
not otherwise defined herein have the meanings assigned under U.S. GAAP, (iii) all references in
this Agreement to designated “Sections” and other subdivisions are to the designated Sections and
other subdivisions of the body of this Agreement, (iv) pronouns of either gender or neuter shall
include, as appropriate, the other pronoun forms, (v) the words “herein”, “hereof” and “hereunder”
and other words of similar import refer to this Agreement as a whole and not to any particular
Section or other subdivision (vi) all references in this Agreement to designated schedules,
exhibits and annexes are to the schedules, exhibits and annexes attached to this Agreement unless
explicitly stated otherwise, (vii) “or” is not exclusive, (viii) the term “including” will be
deemed to be followed by “, but not limited to,”; (ix) the terms “shall”, “will”, and “agrees” are
mandatory, and the term “may” is permissive; (x) the term “day” means “calendar day”, and (xi) all
references to dollars are to currency of the United States of America.

     1.3 Jurisdiction. The terms of this Agreement are drafted primarily in contemplation of an
offering of securities in the United States of America. The parties recognize, however, the
possibility that securities may be qualified or registered in a jurisdiction other than the United
States of America for offering to the public or that the Company might effect an offering in the
United States of America in the form of American Depositary Receipts or American Depositary Shares.
Accordingly:

9

 

          (i) It is their intention that, whenever this Agreement refers to a Law, form, process or
institution of the United States of America but the parties wish to effectuate qualification or
registration in a different jurisdiction, reference in this Agreement to the Laws or institutions
of the United States shall be read as referring, mutatis mutandis, to the
comparable Laws or institutions of the jurisdiction in question; and

          (ii) It is agreed that the Company will not undertake any listing of American Depositary
Receipts, American Depositary Shares or any other security derivative of the Company’s Ordinary
Shares unless arrangements have been made reasonably satisfactory to a Majority-in-Interest of the
Holders (voting as a single class) to ensure that the spirit and intent of this Agreement will be
realized and that the Company is committed to take such actions as are necessary such that the
Holders will enjoy rights corresponding to the rights hereunder to sell their Registrable
Securities in a public offering in the United States of America as if the Company had listed
Ordinary Shares in lieu of such derivative securities.

     1.4 Original Shareholders Agreement. The Parties acknowledge and agree that, notwithstanding
this Agreement, the Original Shareholders Agreement shall continue in full force and effect with
respect to any subject matter thereof that occurs, or pertains to a date, prior to the Effective
Date.

2. Demand Registration.

     2.1 Registration Other Than on Form F-3 or Form S-3. Subject to the terms of this Agreement,
at any time or from time to time after the date that is six (6) months after the closing of the
IPO, the Holders holding fifteen percent (15%) or more of the then outstanding Series A Registrable
Securities, Series B Registrable Securities or Series C Registrable Securities, respectively, may
request in writing that the Company effect a Registration and a listing of the Series A Registrable
Securities, Series B Registrable Securities or Series C Registrable Securities, respectively, on
the stock exchange on which the Ordinary Shares are then listed. Upon receipt of such a request,
the Company shall (x) promptly give written notice of the proposed Registration to all other
Holders, and (y) as soon as practicable, use its reasonable best efforts to cause the Registrable
Securities specified in the request, together with any Registrable Securities of any Holder who
requests in writing to join such Registration within fifteen (15) days after the Company’s delivery
of written notice, to be Registered and/or qualified for sale and distribution in such jurisdiction
as the Initiating Holders may request. The Company shall be obligated to effect no more than three
(3) Registrations pursuant to this Section 2.1 that have been declared and ordered
effective.

     2.2 Registration on Form F-3 or Form S-3. Subject to the terms of this Agreement, if the
Company qualifies for Registration on Form F-3 or Form S-3 (or any comparable form for Registration
in a jurisdiction other than the United States), any Holder may request the Company to file, in any
jurisdiction in which the Company has had a registered underwritten public offering, a Registration
Statement on Form F-3 or Form S-3 (or any comparable form for Registration in a jurisdiction other
than the United States), including without limitation any registration statement filed under the
Securities Act providing for the registration of, and the sale on a continuous or a delayed basis
by such Holder of, all of the Series A Registrable Securities, Series B Registrable Securities or
Series C Registrable Securities held by such Holder pursuant to Rule 415 under the Securities Act
and/or any similar rule that may be adopted by the Commission. Upon receipt of such a request, the
Company shall (i) promptly give written notice of the proposed Registration to all other Holders
and (ii) as soon as practicable, use its reasonable best efforts to cause the Registrable
Securities

10

 

specified in the request, together with any Registrable Securities of any Holder who requests
in writing to join such Registration within fifteen (15) days after the Company’s delivery of
written notice, to be Registered and qualified for sale and distribution in such jurisdiction. The
Company shall be obligated to effect no more than two (2) Registrations that have been declared and
ordered effective within any twelve (12)-month period pursuant to this Section 2.2.

     2.3 Right of Deferral.

          (i) The Company shall not be obligated to Register or qualify Registrable Securities pursuant
to this Section 2:

               (a) if, within ten (10) days of the receipt of any request of the Holders to Register any
Registrable Securities under Section 2.1 or Section 2.2, the Company gives notice
to the Initiating Holders of its bona fide intention to effect the filing for its own account of a
Registration Statement of Ordinary Shares within sixty (60) days of receipt of that request;
provided, that the Company is actively employing in good faith its reasonable best efforts
to cause that Registration Statement to become effective within sixty (60) days of the initial
filing; provided, further, that the Holders are entitled to join such Registration
subject to Section 3; or

               (b) during the period starting with the date of filing by the Company of, and ending six (6)
months following the effective date of any Registration Statement pertaining to Ordinary Shares of
the Company; provided, that the Holders are entitled to join such Registration subject to
Section 3 (other than a registration of securities in a transaction under Rule 145 of the
Securities Act or with respect to an employee benefit plan).

          (ii) If, after receiving a request from Holders pursuant to Section 2.1 or Section
2.2 hereof, the Company furnishes to the Holders a certificate signed by the chief executive
officer of the Company stating that, in the good faith judgment of the Board, there is a reasonable
likelihood that it would be materially detrimental to the Company or its members for a Registration
Statement to be filed in the near future, then the Company shall have the right to defer such
filing for a period during which such filing would be materially detrimental, provided,
that such deferral by the Company shall not exceed ninety (90) days from the receipt of any request
duly submitted by Holders under Section 2.1 or Section 2.2 to Register Registrable
Securities; provided, further, that the Company may not Register any other of its
Securities during such ninety (90) day period (except for Registrations contemplated by Section
3.4); provided, further, that the Company shall not utilize this right more
than once in any twelve (12) month period.

     2.4 Underwritten Offerings. If, in connection with a request to Register Registrable
Securities under Section 2.1 or Section 2.2, the Initiating Holders seek to
distribute such Registrable Securities in an underwritten offering, they shall so advise the
Company as a part of the request, and the Company shall include such information in the written
notice to the other Holders described in Section 2.1 and Section 2.2. In such
event, the right of any Holder to include its Registrable Securities in such Registration shall be
conditioned upon such Holder’s participation in such underwritten offering and the inclusion of
such Holder’s Registrable Securities in the underwritten offering (unless otherwise mutually agreed
by a Majority-in-Interest of the Initiating Holders and such Holder) to the extent provided herein.
All Holders proposing to distribute their securities through such underwritten offering shall enter
into an underwriting agreement in customary form with the underwriter or underwriters

11

 

of internationally recognized standing selected for such underwritten offering by the Company;
provided however, that the Holders shall only be obligated to give representations
and warranties under such underwriting agreement that are customary in similar agreements in
relation to their ownership of the Registrable Securities and due authorization to enter into such
underwriting agreement. Notwithstanding any other provision of this Agreement, if the managing
underwriter advises the Company that marketing factors (including without limitation the aggregate
number of securities requested to be Registered, the general condition of the market, and the
status of the Persons proposing to sell securities pursuant to the Registration) require a
limitation of the number of Registrable Securities to be underwritten in a Registration pursuant to
Section 2.1 or Section 2.2, the underwriters may exclude from the underwritten
offering up to seventy-five percent (75%) of the Registrable Securities requested to be Registered
but only after first excluding all other Equity Securities held by any director, officer, employee
or consultant of the Company or any other holder of Ordinary Shares of the Company from the
Registration and underwritten offering and so long as the number of shares to be included in the
Registration on behalf of the non-excluded Holders is allocated among all Holders in proportion, as
nearly as practicable, to the respective amounts of Registrable Securities requested by such
Holders to be included, provided, that if, as a result of such underwriter cutback, the
Holders cannot include in the underwritten offering all of the Registrable Securities that they
have requested to be included therein, then such Registration shall not be deemed to constitute one
of the three (3) demand Registrations to which the Holders are entitled pursuant to Section
2.1. Any Registrable Securities excluded or withdrawn from such underwritten offering shall be
withdrawn from the Registration.

3. Piggyback Registrations.

     3.1 Registration of the Company’s Securities. Subject to the terms of this Agreement, if the
Company proposes to Register for its own account any of its Equity Securities (including in respect
of any IPO subject to the rights set forth in Section 4 below), or for the account of any
holder (other than a Holder) of Equity Securities any of such holder’s Equity Securities, in
connection with the public offering of such securities solely for cash (except as set forth in
Section 3.4), the Company shall promptly give each Holder written notice of such
Registration and, upon the written request of any Holder given within fifteen (15) days after
delivery of such notice, the Company shall use its best efforts to include in such Registration any
Registrable Securities thereby requested to be Registered by such Holder. If a Holder decides not
to include all or any of its Registrable Securities in such Registration by the Company, such
Holder shall nevertheless continue to have the right to include any Registrable Securities in any
subsequent Registration Statement or Registration Statements as may be filed by the Company, all
upon the terms and conditions set forth herein.

     3.2 Right to Terminate Registration. The Company shall have the right to terminate or
withdraw any Registration initiated by it under Section 3.1 prior to the effectiveness of
such Registration, whether or not any Holder has elected to participate therein. The expenses of
such withdrawn Registration shall be borne by the Company in accordance with Section 5.3.

     3.3 Underwriting Requirements.

          (i) In connection with any offering involving an underwriting of the Company’s Equity
Securities solely for cash, the Company shall not be required to Register the Registrable
Securities of a Holder under this Section 3 unless such Holder’s Registrable Securities are
included in the underwritten offering and such Holder enters into an

12

 

underwriting agreement in customary form with the underwriter or underwriters of
internationally recognized standing selected by the Company and setting forth such terms for the
underwritten offering as have been agreed upon between the Company and the underwriters;
provided however, that the Holders shall only be obligated to give representations
and warranties under such underwriting agreement that are customary in similar agreements in
relation to their ownership of the Registrable Securities and due authorization to enter such
underwriting agreement. In the event the underwriters advise Holders seeking Registration of
Registrable Securities pursuant to this Section 3 in writing that market factors (including
the aggregate number of Registrable Securities requested to be Registered, the general condition of
the market, and the status of the Persons proposing to sell securities pursuant to the
Registration) require a limitation of the number of Registrable Securities to be underwritten, the
underwriters may exclude from the underwriting offering (x) in the case of a Qualified IPO, subject
to the obligations of the parties set forth in Section 4, up to all of the Registrable
Securities requested to be registered, and (y) in other cases, up to seventy-five percent (75%) of
the Registrable Securities requested to be Registered but, in each case, only after first excluding
all other Equity Securities held by any director, officer, employee or consultant of the Company or
any other holder of Ordinary Shares of the Company from the Registration and underwriting and so
long as the Registrable Securities to be included in such Registration on behalf of any
non-excluded Holders are allocated among all Holders in proportion, as nearly as practicable, to
the respective amounts of Registrable Securities requested by such Holders to be included.

          (ii) If any Holder disapproves the terms of any underwriting, the Holder may elect to withdraw
therefrom by written notice to the Company and the underwriters delivered at least ten (10) days
prior to the effective date of the Registration Statement. Any Registrable Securities excluded or
withdrawn from the underwritten offering shall be withdrawn from the Registration. Notwithstanding
the foregoing, the Company shall not be required to pay for any expenses of any Registration
proceeding begun pursuant to Section 2.1 or Section 2.2 if the Registration request
is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities
to be registered (in which case all participating Holders shall bear such expenses pro rata based
upon the number of Registrable Securities that were to be included in the withdrawn registration).

     3.4 Exempt Transactions. The Company shall have no obligation to Register any Registrable
Securities under this Section 3 in connection with a Registration by the Company (i)
relating solely to the sale of securities to participants in a Company share plan, or (ii) relating
to a corporate reorganization or other transaction under Rule 145 of the Securities Act (or
comparable provision under the Laws of another jurisdiction, as applicable); (iii) on any form that
does not include substantially the same information as would be required to be included in a
registration statement covering the sale of the Registrable Securities, or (iv) relating to a
registration in which the only Ordinary Shares being registered are Ordinary Shares issuable upon
conversion of debt securities that are also being registered.

4. Right to IPO Directed Shares. To the extent permitted by applicable Law and regulations, the
Company, the Founders and the Ordinary Shareholders shall use their respective best efforts to
procure the Company’s underwriters to direct that up to twenty five percent (25%) (or any lesser
amount as requested by the Series A and Series B Lead Investor) of the proposed shares to be
registered in connection with the Company’s first IPO be Registrable Securities held by the
Investors, with such directed shares to be allocated to the Investors on a pro rata basis in
accordance with their respective ownership of the Registrable Securities.

13

 

5. Registration Procedures.

     5.1 Registration Procedures and Obligations. Whenever required under this Agreement to effect
the Registration of any Registrable Securities held by the Holders, the Company shall, as
expeditiously as reasonably possible:

          (i) Prepare and file with the Commission a Registration Statement with respect to those
Registrable Securities and use its reasonable best efforts to cause that Registration Statement to
become effective, and, upon the request of the Holders holding a majority of the Registrable
Securities Registered thereunder, keep the Registration Statement effective for up to one hundred
and eighty (180) days or, if earlier, until the distribution thereunder has been completed;
provided, however, that (a) such one hundred and eighty (180) day period shall be
extended for a period of time equal to the period any Holder refrains from selling any Registrable
Securities included in such Registration at the written request of the underwriter(s) for such
Registration, and (b) in the case of any Registration of Registrable Securities on Form S-3 or Form
F-3 that are intended to be offered on a continuous or delayed basis, subject to compliance with
applicable rules promulgated by the Securities and Exchange Commission, such 180-day period shall
be extended for up to an additional sixty (60) days, if necessary, to keep the registration
statement effective until all such Registrable Securities are sold;

          (ii) Prepare and file with the Commission amendments and supplements to that Registration
Statement and the prospectus used in connection with the Registration Statement as may be necessary
to comply with the provisions of Applicable Securities Laws with respect to the disposition of all
securities covered by the Registration Statement;

          (iii) Furnish to the Holders the number of copies of a prospectus, including a preliminary
prospectus, required by Applicable Securities Laws, and any other documents as they may reasonably
request in order to facilitate the disposition of Registrable Securities owned by them;

          (iv) Use its reasonable best efforts to Register and qualify the securities covered by the
Registration Statement under the securities Laws of any jurisdiction, as reasonably requested by
the Holders, provided, that the Company shall not be required to qualify to do business or
file a general consent to service of process in any such jurisdictions;

          (v) In the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in customary form, with the managing underwriter(s) of the
offering. Each shareholder participating in the underwritten offering shall also enter into and
perform its obligations under such an agreement;

          (vi) Notify each Holder of Registrable Securities covered by the Registration Statement at any
time when a prospectus relating thereto is required to be delivered under Applicable Securities
Laws of (a) the issuance of any stop order by the Commission, or (b) the happening of any event as
a result of which any prospectus included in the Registration Statement, as then in effect,
includes an untrue statement of a material fact or omits to state a material fact required to be
stated therein or necessary to make the statements therein not misleading in the light of the
circumstances then existing;

          (vii) Provide a transfer agent and registrar for all Registrable Securities Registered
pursuant to the Registration Statement and, where applicable, a number assigned by

14

 

the Committee on Uniform Securities Identification Procedures for all those Registrable
Securities, in each case not later than the effective date of the Registration; and

          (viii) Take all reasonable action necessary to list the Registrable Securities on the primary
exchange on which the Company’s securities are then traded or in connection with a Qualified IPO,
the primary exchange on which the Company’s securities will be traded.

     5.2 Information from Holder. It shall be a condition precedent to the obligations of the
Company to take any action pursuant to this Agreement with respect to the Registrable Securities of
any selling Holder that such Holder shall furnish to the Company such information regarding itself,
the Registrable Securities held by it, and the intended method of disposition of such securities as
shall be required to effect the Registration of such Holder’s Registrable Securities.

     5.3 Expenses of Registration. All expenses, other than the underwriting discounts and selling
commissions applicable to the sale of Registrable Securities pursuant to this Agreement (which
shall be borne by the Holders requesting Registration on a pro rata basis in proportion to their
respective numbers of Registrable Securities sold in such Registration), incurred in connection
with Registrations, filings or qualifications pursuant to this Agreement, including (without
limitation) all Registration, filing and qualification fees, printers’ and accounting fees, fees
and disbursements of counsel for the Company and reasonable fees and disbursements of one counsel
for all selling Holders, shall be borne by the Company. The Company shall not, however, be required
to pay for any expenses of any Registration proceeding begun pursuant to this Agreement if the
Registration request is subsequently withdrawn at the request of a Majority-in-Interest of the
Holders requesting such Registration (in which case all participating Holders shall bear such
expenses pro rata based upon the number of Registrable Securities that were to be thereby
Registered in the withdrawn Registration).

6. Registration-Related Indemnification.

     6.1 Company Indemnity.

          (i) To the maximum extent permitted by Law, the Company will indemnify and hold harmless each
Holder, such Holder’s partners, officers, directors, shareholders, legal counsel and accountants,
any underwriter (as defined in the Securities Act) and each Person, if any, who controls (as
defined in the Securities Act) such Holder or underwriter, against any losses, claims, damages or
liabilities (joint or several) to which they may become subject under Laws which are applicable to
the Company and relate to action or inaction required of the Company in connection with any
Registration, qualification, or compliance, insofar as such losses, claims, damages, or liabilities
(or actions in respect thereof) arise out of or are based upon any of the following statements,
omissions or violations (each a “Violation”): (a) any untrue statement or alleged untrue statement
of a material fact contained in such Registration Statement, on the effective date thereof
(including any preliminary prospectus or final prospectus contained therein or any amendments or
supplements thereto), (b) the omission or alleged omission to state in the Registration Statement,
on the effective date thereof (including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto), a material fact required to be stated therein or
necessary to make the statements therein not misleading, or (c) any violation or alleged violation
by the Company of Applicable Securities Laws, or any rule or regulation promulgated under
Applicable Securities Laws. The Company will reimburse each such Holder, underwriter or
controlling person for

15

 

any legal or other expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability or action.

          (ii) The indemnity agreement contained in this Section 6.1 shall not apply to amounts
paid in settlement of any such loss, claim, damage, liability or action if such settlement is
effected without the consent of the Company (which consent shall not be unreasonably withheld or
delayed), nor shall the Company be liable in any such case for any such loss, claim, damage,
liability or action to the extent that it arises solely out of or is solely based upon a Violation
that occurs in reliance upon and in conformity with written information furnished for use in
connection with such Registration by any such Holder, underwriter or controlling person. Further,
the foregoing indemnity agreement with respect to any preliminary prospectus shall not inure to the
benefit of any Holder or other aforementioned person, or any person controlling such Holder, from
whom the person asserting any such losses, claims, damages or liabilities purchased shares in the
offering, if a copy of the most current prospectus was not sent or given by or on behalf of such
Holder or other aforementioned person to such person, if required by Law to have been so delivered,
at or prior to the written confirmation of the sale of the shares to such person, and if the
prospectus (as so amended or supplemented) would have cured the defect giving rise to such loss,
claim, damage or liability.

     6.2 Holder Indemnity.

          (i) To the maximum extent permitted by Law, each selling Holder will severally but not jointly
indemnify and hold harmless the Company, its directors, officers, legal counsel and accountants,
any underwriter, any other Holder selling securities in connection with such Registration and each
Person, if any, who controls (within the meaning of the Securities Act) the Company, such
underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several)
to which any of the foregoing persons may become subject, under Applicable Securities Laws, or any
rule or regulation promulgated under Applicable Securities Laws, insofar as such losses, claims,
damages or liabilities (or actions in respect thereto) arise out of or are based upon any
Violation, in each case to the extent (and only to the extent) that such Violation occurs in
reliance upon and in conformity with written information furnished by such Holder for use in
connection with such Registration; and each such Holder will reimburse any Person intended to be
indemnified pursuant to this Section 6.2, for any legal or other expenses reasonably
incurred by such Person in connection with investigating or defending any such loss, claim, damage,
liability or action. No Holder’s liability under this Section 6.2 shall exceed the net
proceeds (less underwriting discounts and selling commissions) received by such Holder from the
offering of securities made in connection with that Registration.

          (ii) The indemnity contained in this Section 6.2 shall not apply to amounts paid in
settlement of any such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Holder (which consent shall not be unreasonably withheld or delayed).

     6.3 Notice of Indemnification Claim. Promptly after receipt by an indemnified party under
Section 6.1 or Section 6.2 of notice of the commencement of any action (including
any governmental action), such indemnified party will, if a claim in respect thereof is to be made
against any indemnifying party under Section 6.1 or Section 6.2, deliver to the
indemnifying party a written notice of the commencement thereof and the indemnifying party shall
have the right to participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly noticed, to assume the defense thereof with

16

 

counsel mutually satisfactory to the indemnifying parties. An indemnified party (together
with all other indemnified parties that may be represented without conflict by one counsel) shall
have the right to retain one separate counsel, with the reasonably incurred fees and expenses to be
paid by the indemnifying party, if representation of such indemnified party by the counsel retained
by the indemnifying party would be inappropriate due to actual or potential differing interests
between such indemnified party and any other party represented by such counsel in such proceeding.
The failure to deliver written notice to the indemnifying party within a reasonable time of the
commencement of any such action, if prejudicial to its ability to defend such action, shall relieve
such indemnifying party, to the extent so prejudiced, of any liability to the indemnified party
under this Section 6, but the omission to deliver written notice to the indemnifying party
will not relieve it of any liability that it may have to any indemnified party otherwise than under
this Section 6.

     6.4 Contribution. If any indemnification provided for in Section 6.1 or Section
6.2 is held by a court of competent jurisdiction to be unavailable to an indemnified party with
respect to any loss, liability, claim, damage or expense referred to herein, the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount
paid or payable by such indemnified party as a result of such loss, liability, claim, damage or
expense in such proportion as is appropriate to reflect the relative fault of the indemnifying
party, on the one hand, and of the indemnified party, on the other, in connection with the
statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as
any other relevant equitable considerations. The relative fault of the indemnifying party and of
the indemnified party shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and the parties’
relative intent, knowledge, access to information, and opportunity to correct or prevent such
statement or omission. No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation.

     6.5 Underwriting Agreement. To the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the
underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control.

     6.6 Survival. The obligations of the Company and Holders under this Section 6 shall
survive the completion of any offering of Registrable Securities in a Registration Statement under
this Agreement.

7. Additional Registration-Related Undertakings.

     7.1 Reports under the Exchange Act. With a view to making available to the Holders the
benefits of Rule 144 promulgated under the Securities Act and any comparable provision of any
Applicable Securities Laws that may at any time permit a Holder to sell securities of the Company
to the public without Registration or pursuant to a Registration on Form F-3 or Form S-3 (or any
comparable form in a jurisdiction other than the United States), the Company agrees to:

          (i) make and keep public information available, as those terms are understood and defined in
Rule 144 (or comparable provision, if any, under Applicable Securities Laws in any jurisdiction
where the Company’s securities are listed), at all times

17

 

following ninety (90) days after the effective date of the first Registration under the
Securities Act filed by the Company for an offering of its securities to the general public;

          (ii) file with the Commission in a timely manner all reports and other documents required of
the Company under all Applicable Securities Laws; and

          (iii) at any time following ninety (90) days after the effective date of the first
Registration under the Securities Act filed by the Company for an offering of its securities to the
general public by the Company, promptly furnish to any Holder holding Registrable Securities, upon
request (a) a written statement by the Company that it has complied with the reporting requirements
of all Applicable Securities Laws at any time after it has become subject to such reporting
requirements or, at any time after so qualified, that it qualifies as a registrant whose securities
may be resold pursuant to Form F-3 or Form S-3 (or any form comparable thereto under Applicable
Securities Laws of any jurisdiction where the Company’s securities are listed), (b) a copy of the
most recent annual or quarterly report of the Company and such other reports and documents as filed
by the Company with the Commission, and (c) such other information as may be reasonably requested
in availing any Holder of any rule or regulation of the Commission, that permits the selling of any
such securities without Registration or pursuant to Form F-3 or Form S-3 (or any form comparable
thereto under Applicable Securities Laws of any jurisdiction where the Company’s Securities are
listed).

     7.2 Limitations on Subsequent Registration Rights. From and after the date of this Agreement,
the Company shall not, without the prior written consent of the Series A and Series B Lead
Investor, enter into any agreement with any holder or prospective holder of any Equity Securities
of the Company that would allow such holder or prospective holder (i) to include such Equity
Securities in any Registration filed under Section 2, Section 3 or Section
4, unless under the terms of such agreement such holder or prospective holder may include such
Equity Securities in any such Registration only to the extent that the inclusion of such Equity
Securities will not reduce the amount of the Registrable Securities of the Holders that are
included, (ii) to demand Registration of their securities on a basis more favorable to such holder
or prospective holder than is provided to the Holders thereunder or without providing the Holders
corresponding piggyback registration rights to such demand registration rights thereunder, or (iii)
cause the Company to include such Equity Securities in any Registration filed under Section
2, Section 3 or Section 4 hereof on a basis more favorable to such holder or
prospective holder than is provided to the Holders thereunder.

     7.3
“Market Stand-Off” Agreement. Each Holder agrees, if so required by the managing
underwriter(s), that it will not during the period commencing on the date of the final prospectus
relating to the Company’s IPO and ending on the date specified by the Company and the managing
underwriter (such period not to exceed one hundred eighty (180) days from the date of such final
prospectus) (i) lend, offer, pledge, hypothecate, hedge, sell, make any short sale of, loan,
contract to sell, sell any option or contract to purchase, purchase any option or contract to sell,
grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, any Equity Securities (other than those included in such offering) or (ii) enter into
any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of the Equity Securities, whether any such transaction described in
clause (i) or (ii) above is to be settled by delivery of Equity Securities or such other
securities, in cash or otherwise; provided, that (x) all directors, officers and all other
holders of share capital of the Company must be bound by restrictions substantially identical to
those applicable to any Holder pursuant to this Section 7.3, (y) all Holders will be
released from any restrictions set forth in this Section 7.3 to the extent that any

18

 

other members subject to substantially similar restrictions are released, and (z) the lockup
agreements shall permit Holders to transfer their Registrable Securities to their respective
Affiliates so long as the transferees enters into the same lockup agreement. The underwriters in
connection with the Company’s IPO are intended third party beneficiaries of this Section
7.3 and shall have the right, power and authority to enforce the provisions hereof as though
they were a party hereto. In order to enforce the foregoing covenant, the Company may place
restrictive legends on the certificates and impose stop-transfer instructions with respect to the
Registrable Securities of each shareholder (and the shares or securities of every other person
subject to the foregoing restriction) until the end of such period.

     7.4 Termination of Registration Rights. The registration rights and obligations set forth in
Section 2, Section 3 and Section 4 of this Agreement shall terminate on the
later of (i) the date that is five (5) years from the date of closing of a Qualified IPO, (ii) a
Sale of the Company, and (iii) with respect to any Holder, the date on which such Holder may sell
all of its Registrable Securities under Rule 144 of the Securities Act in any ninety (90)-day
period without limitation as to volume or manner of sale.

     7.5 Exercise of Preferred Shares. Notwithstanding anything to the contrary provided in this
Agreement, the Company shall have no obligation to Register Registrable Securities which, if
constituting Ordinary Share Equivalents, have not been exercised, converted or exchanged, as
applicable, for Ordinary Shares.

8. Preemptive Right.

     8.1 General. The Company hereby grants to each holder of Series A Preferred Shares, Series B
Preferred Shares and Series C Preferred Shares (each, a “Preferred Share Holder”) a right to
purchase any New Securities that the Company may, from time to time, propose to sell or issue to
any investors, in the proportions set forth in this Section 8.

     8.2 Preferred Share Holder Notice. In the event the Company proposes to undertake an issuance
of New Securities, the Company shall deliver to each Preferred Share Holder written notice (the
“Preferred Share Holder Notice”) specifying (i) the type of New Securities, (ii) the identity of
the prospective purchaser, and (iii) the price and the terms upon which the Company proposes to
issue the same. Each Preferred Share Holder shall have fifteen (15) days (the “Preferred Share
Holder Participation Period”) after the receipt of the Preferred Share Holder Notice to agree to
purchase up to such Preferred Share Holder’s respective pro rata share (as defined below) of such
New Securities (as determined in Section 8.3 below) for the price and upon the terms
specified in the Preferred Share Holder Notice by giving written notice to the Company and stating
therein the quantity of New Securities to be purchased.

     8.3 Pro Rata Share. Each Preferred Share Holder’s “pro rata share” for purposes of the
preemptive right specified in this Section 8 shall be determined according to the aggregate
number of Ordinary Shares owned by such Preferred Share Holder immediately prior to the issuance of
the New Securities (assuming the exercise, conversion or exchange of all then outstanding Ordinary
Share Equivalents) in relation to the total number of Ordinary Shares of the Company owned by all
Preferred Share Holders immediately prior to the issuance of the New Securities (assuming the
exercise, conversion or exchange of all then outstanding Common Share Equivalents).

19

 

     8.4 Overallotment. If any Preferred Share Holder fails to exercise its right to purchase its
full pro rata share of the New Securities (each, a “Non-Exercising Holder”), the Company shall,
within five (5) days after the expiration of the Preferred Share Holder Participation Period,
deliver written notice specifying the aggregate number of remaining New Securities that were
eligible for purchase by all Non-Exercising Holders (the “Remaining Securities”) to each Preferred
Share Holder that exercised its right to purchase its full pro rata share of the New Securities
(each, an “Exercising Holder”). Each Exercising Holder shall have a right of overallotment, and
may exercise an additional right to purchase the Remaining Securities by notifying the Company in
writing within ten (10) days after receipt of the notice by the Company pursuant to the prior
sentence of this Section 8.4; provided, however, that if the Exercising
Holders desire to purchase in aggregate more than the number of the Remaining Securities, then the
Remaining Securities will be allocated to the extent necessary among the Exercising Holders in
accordance with their relative pro rata shares.

     8.5 Sales by the Company. If, after compliance in full with the requirements of Sections
8.1 to 8.4 above, the other Preferred Share Holders have not elected to purchase any
New Securities, for a period of thirty (30) days following the expiration of the ten (10) day
period referred to in Section 8.4 above or of the Preferred Share Holder Participation
Period (in the event that Section 8.4 is not relevant with respect to the proposed sale of
New Securities), the Company may sell any New Securities with respect to which the Preferred Share
Holders’ rights under this Section 8 were not exercised, to the purchasers identified in
the Preferred Share Holder Notice and at a price and upon terms not more favorable to the
purchasers thereof than specified in the Preferred Share Holder Notice. In the event the Company
has not sold such New Securities within such thirty (30) day period, the Company shall not
thereafter issue or sell any New Securities, without first again offering such securities to the
Preferred Share Holders in the manner provided in this Section 8.

     8.6 Termination of Preemptive Rights. The preemptive rights in this Section 8 shall
terminate on the earlier of (i) the closing of a Qualified IPO, or (ii) a Liquidation Event.

9. Drag Along Rights.

     9.1 General. Subject to, without limitation, the Memorandum and Articles, if, at any time
following the second anniversary of the date hereof and prior to the closing of a Qualified IPO,
the Series A and Series B Lead Investor and holders together in the aggregate holding at least a
majority of the aggregate number of the Company’s outstanding Ordinary Shares and Preferred Shares,
voting together on an as-converted basis (the “Accepting Shareholders”) agree in writing to sell or
transfer all of their respective Equity Securities in any proposed Change-of-Control Event, then
the Company shall promptly notify each of the remaining holders of Ordinary Shares and Preferred
Shares (the “Remaining Shareholders”) in writing of such agreement and the material terms and
conditions of such proposed Change-of-Control Event, whereupon each Remaining Shareholder shall, in
accordance with instructions received from the Company, vote all of its Ordinary Shares and/or
Preferred Shares in favor of, otherwise consent in writing to, and/or otherwise sell or transfer
all of its Equity Securities in such Change-of-Control Event (including without limitation
tendering original share certificates for transfer, signing and delivering share transfer forms,
share sale or exchange agreements, and certificates of indemnity relating to any shares in the
event that such Remaining Shareholder has lost or misplaced the relevant share certificate) on the
same terms and conditions as were agreed to by the Accepting Shareholders; provided,
however, that such terms and conditions, including with respect to price paid or received
per Equity Security, may differ as between different classes of Equity Securities;
provided, further, that holders of

20

 

Preferred Shares shall have the right to convert the Preferred Shares held by them into Ordinary
Shares in accordance with the Memorandum and Articles before any proposed Change-of-Control Event.
In furtherance of the foregoing, each Party hereto that may be a Remaining Shareholder hereby
agrees to, and each director of the Company is hereby expressly authorized by each Remaining
Shareholder to take on such Remaining Shareholder’s behalf (without receipt of any further consent
by such Remaining Shareholder), any or all of the following actions: (i) vote as irrevocable proxy
for such Remaining Shareholder at an extraordinary general meeting of the Company (this Agreement
constituting a valid form of irrevocable proxy coupled with an interest in substitution approved by
the Board of Directors) or execute a shareholders written resolution in respect of all of the
voting securities of such Remaining Shareholder in favor of any such proposed Change-of-Control
Event; (ii) otherwise consent on such Remaining Shareholder’s behalf to such proposed
Change-of-Control Event; (iii) sell all of such Remaining Shareholder’s Shares in such proposed
Change-of-Control Event, in accordance with the terms and conditions of this Section 9.1;
and/or (iv) act as the Remaining Shareholder’s attorney-in-fact in relation to any such proposed
Change-of-Control Event and have the full authority to sign and deliver, on behalf of such
Remaining Shareholder, shareholders unanimous written resolutions referenced to in (i) above or a
form of irrevocable proxy coupled with an interest in substitution for the proxy constituted by
this Agreement, share transfer forms, share sale or exchange agreements and certificates of
indemnity relating to any Shares in the event that such Remaining Shareholder has lost or misplaced
the relevant share certificate. Notwithstanding the foregoing provisions of this Section
9.1, the Remaining Shareholders shall not be obligated to vote, consent and/or sell their
Equity Securities in connection with any such proposed Change-of-Control Event to the extent that
(i) the Accepting Shareholders do not also do so with respect to all of the applicable classes or
series of Equity Securities held by them, or (ii) such proposed Change-of-Control Event provides
for or implies a sale price of Ordinary Shares of less than $8.00 per share on an as-if-converted
basis.

     9.2 Termination of Drag Along Rights. The drag along rights in this Section 9 shall
terminate on the earlier of (i) the closing of a Qualified IPO, or (ii) a Liquidation Event.

10. Information and Inspection Rights; Tax Matters.

     10.1 Delivery of Financial Statements. As long as any Preferred Shares remain outstanding,
the Company shall deliver to each holder of Preferred Shares the following documents or reports:

          (i) within ninety (90) days after the end of each fiscal year of the Company beginning 2008, a
consolidated income statement and statement of cash flows for the Company for such fiscal year and
a consolidated balance sheet for the Company as of the end of the fiscal year, audited and
certified by a “big four” firm of independent certified public accountants or such other accounting
firm that is registered with the Public Company Accounting Oversight Board and approved by the
Board, including all Preferred Directors (except that in the event any holder or holders of
Preferred Shares elect not to designate a Preferred Director such holder(s) have the right to
designate, then the approval of any Board Observer designated pursuant to Section 11.8(i),
if any, shall be required), if any, and a management report including a comparison of the financial
results of such fiscal year with the corresponding annual budget, all prepared in English and in
accordance with U.S. GAAP;

          (ii) within forty-five (45) days after the end of each fiscal quarter of the Company, a
consolidated unaudited income statement and statement of cash flows for such

21

 

fiscal quarter and a consolidated unaudited balance sheet for the Company as of the end of such
fiscal quarter, and a management report including a comparison of the financial results of such
fiscal year with the corresponding quarterly budget, all prepared in English and in accordance with
U.S. GAAP (except for year-end adjustments and except for the absence of notes);

          (iii) within thirty (30) days of the end of each month, a consolidated unaudited income
statement and statement of cash flows for such month and a consolidated balance sheet for the
Company as of the end of such month, and a management report all prepared in English and in
accordance with U.S. GAAP (except for year-end adjustments and except for the absence of notes);

          (iv) no later than thirty (30) days prior to the end of each fiscal year, an annual budget for
the succeeding fiscal year; and

          (v) copies of all documents or other information sent to other shareholders and any reports
publicly filed by the Company with any relevant securities exchange, regulatory authority or
governmental agency, no later than five (5) days after such documents or information are sent or
filed by the Company.

     10.2 Inspection. The members of the Company Group shall permit any Investor, at such
Investor’s own expense, to visit and inspect, during normal business hours following reasonable
notice by the Investor to the Company (which shall be no less than three (3) days unless otherwise
agreed by the Company), any of the properties of the member of the Company Group, and examine the
books of account and records of any member of the Company Group, and discuss the affairs, finances
and accounts of any member of the Company Group with the directors, officers, management employees,
accountants, legal counsel and investment bankers of such companies, all at such reasonable times
as may be requested in writing by the Investor; provided, that the Investor agrees to keep
confidential any information so obtained in accordance with Section 8.1 of the Series A
Share Purchase Agreement, the Series B Share Purchase Agreement and the Series C Share Purchase
Agreement.

     10.3 Termination of Information and Inspection Rights. The rights and covenants set forth in
Sections 10.1 and 10.2 shall terminate and be of no further force or effect upon
the earlier occurrence of (i) the closing of a Qualified IPO or (ii) a Liquidation Event.

     10.4 Governmental/Securities Filings. For three (3) years after the time when the Company
becomes subject to the filing requirements of the Exchange Act or any other organized securities
exchange, as long as an Investor holds any Equity Securities, the Company shall deliver to such
Investor copies of, or provide a link on its public website to, any quarterly, annual,
extraordinary, or other reports publicly filed by the Company with the Commission or any other
relevant securities exchange, regulatory authority or government agency, and any annual reports and
other materials provided to all other shareholders of the Company.

     10.5 United States Tax Matters.

          (i) The Company will not take any action inconsistent with the treatment of the Company as a
corporation for U.S. federal income tax purposes and will not elect to be treated as an entity
other than a corporation for U.S. federal income tax purposes.

          (ii) The Company will use, and will cause each of its Subsidiaries to use, reasonable best
efforts to avoid classification as a passive foreign investment company

22

 

(“PFIC”) as defined in the Internal Revenue Code of 1986, as amended (the “Code”) for the current
year or any subsequent year.

          (iii) The Company shall promptly provide each U.S. Holder with written notice if it (or any of
the other members of the Company Group) becomes a PFIC or a “controlled foreign corporation”
(“CFC”) as defined under the Code. Such notice shall include a reasonably detailed analysis of the
determination that the Company (or any of the other members of the Company Group) has become a PFIC
or CFC.

          (iv) The Company shall make due inquiry with its tax advisors on at least an annual basis
regarding its status as a PFIC (and the status of each of the other Group Companies), and if the
Company is informed by its tax advisors that any such entity has become a PFIC, or that there is a
likelihood of any such entity being classified as a PFIC for any taxable year, the Company shall
promptly notify each U.S. Holder of such status or risk, as the case may be. The Company agrees to
make available to each U.S. Holder upon request, the books and records of the Company and the other
Group Companies, and to provide information to each U.S. Holder pertinent to the Company’s (or any
of the other Group Companies’) status or potential status as a PFIC. Upon a determination by the
Company, any U.S. Holder or any taxing authority that the Company (or any of the other Group
Companies) has been or is likely to become a PFIC, the Company will provide each U.S. Holder with
all information reasonably available to the Company to permit such U.S. Holder to (a) accurately
prepare all tax returns and comply with any reporting requirements as a result of such
determination and (b) make any election (including, without limitation, a “qualified electing fund”
election under Section 1295 of the Code), with respect to the Company (or any of the other Group
Companies), and comply with any reporting or other requirements incident to such election. If a
determination is made by the Company, any U.S. Holder or any taxing authority that the Company or
any other Group Company is a PFIC for a particular year, then for such year and for each year
thereafter, the Company will also provide each U.S. Holder with a completed “PFIC Annual
Information Statement” in the form of Exhibit B attached hereto as required by Treasury
Regulation Section 1.1295-1(g) and otherwise comply with applicable Treasury Regulation
requirements. In the event that any U.S. Holder who has made a “qualified electing fund” election
must include in its gross income for a particular taxable year its pro rata share of the Company’s
earnings and profits pursuant to Section 1293 of the Code, the Company agrees to make a dividend
distribution to such U.S. Holder (no later than ninety (90) days following the end of the taxable
year of such U.S. Holder) in an amount equal to fifty percent (50%) of the amount so included by
such U.S. Holder.

          (v) The Company shall provide each U.S. Holder with information relating to the transfer of
any equity interests of the Company and the issuance or redemption by the Company of any equity
interests. No later than two (2) months following the end of the Company’s taxable year, the
Company shall provide the following information to each U.S. Holder: (a) the Company’s
capitalization table as of the end of the last day of such taxable year and (b) a report regarding
the Company’s status as a CFC, if any. The Company shall: (x) furnish to each U.S. Holder upon its
reasonable request, on a timely basis, all information necessary to satisfy the U.S. income tax
return filing requirements of such U.S. Holder (and each “United States shareholder” of the Company
as defined by Section 951(b) of the Code that owns a direct or indirect interest in such U.S.
Holder (a “U.S. Shareholder”)) arising from its investment in the Company and relating to the
Company or any other Group Company’s classification as a CFC; and (y) use commercially reasonable
efforts to avoid generating for any taxable year in which the Company or any other Group Company is
a CFC, amounts

23

 

includible in the income of any U.S. Holder or U.S. Shareholder pursuant to Section 951 of the Code
(a “Section 951 Inclusion”). If the Company or the relevant Group Company ceases to be a CFC at
any time, the Company will provide prompt written notice to each U.S. Holder if at any time
thereafter the Company becomes aware that it or any member of the Company Group has become a CFC.
Upon written request of a U.S. Holder from time to time, subject to obtaining the consent of its
shareholders to release such information, the Company will promptly provide in writing such
information in its possession concerning its shareholders and, to the Company’s actual knowledge,
the direct and indirect interest holders in each shareholder sufficient for such U.S. Holder to
determine whether the Company is a CFC. If any U.S. Holder or U.S. Shareholder has a Section 951
Inclusion for any taxable year (such U.S. Holder or U.S. Shareholder, a “Taxable CFC
Shareholder”), the Company shall distribute cash pro rata with respect to each Ordinary Share so
that the aggregate amount distributed to each Taxable CFC Shareholder equals fifty percent (50%) of
the Section 951 Inclusion of such Taxable CFC Shareholder for such taxable year.

          (vi) The Company will comply and will cause each of the other Group Companies to comply with
all record-keeping, reporting, and other requests necessary for the Company and the other Group
Companies to allow each U.S. Holder to comply with any applicable U.S. federal income tax Law.

          (vii) The cost incurred by the Company in providing the information that it is required to
provide, or is required to cause to be provided, and the cost incurred by the Company in taking the
action, or causing the action to be taken, as described in this Section 10 shall be borne
by the Company.

     10.6 PRC and Cayman Tax Matters

          (i) The Company represents and warrants to the Investors that the Company is not a “resident
enterprise” of China, as defined by Article 2 of the People’s Republic of China Enterprise Income
Tax Law (“PRC Resident Enterprise”), that the Company will use its best effort to arrange its
management activities in such a way as to avoid being a PRC Resident Enterprise in each taxable
year during the period in which the Investors or their successors or assigns hold shares in the
Company, and that neither the Company nor its shareholders are subject to any Tax in the Cayman
Islands. The Company further represents and warrants to the Investors that any and all dividends
to be paid to the Investors shall be made free and clear of, and without deduction for, any Taxes.

          (ii) The Company agrees that, in the event the Company shall deduct any Taxes from or in
respect of any dividends payable to any of the Investors, (a) the dividends payable shall be
increased as necessary so that after making all required deductions (including deductions
applicable to additional sums payable under this paragraph (ii)), each of the Investors receives an
amount equal to the sum it would have received had no such deductions been made, (b) the Company
shall make such deductions, (c) the Company shall pay the full amount deducted to the relevant
taxation authority or other authority in accordance with applicable Laws, and (d) as promptly as
practicable after the date of such payment, the Company shall furnish to the relevant Investors the
original or a certified copy of a receipt evidencing payment thereof.

          (iii) Without limiting the provisions of paragraph (ii) above, the Company agrees to indemnify
such Investor(s) from and against the entirety of the amounts the Company undertakes to pay in
paragraph (ii) above.

24

 

11. Election of Directors.

     11.1 Board of Directors.

          (i) Unless otherwise indicated below, immediately after the Closing, the Company shall have a
Board consisting of seven (7) directors, of which, (a) one (1) Director is to be designated by the
Series A and Series B Lead Investor (the “Preferred Director”); and (b) six (6) Directors are to be
designated by the Founders and approved by holders of at least a majority of the then outstanding
Ordinary Shares (the “Ordinary Directors”), voting separately from the Preferred Shares as a single
class.

          (ii) In the event that (a) redemption of the Preferred Shares or a Qualified IPO has not
occurred on or before January 28, 2013, the fifth anniversary of the escrow release date in
connection with the offering of the Series A Preferred Shares (the “Fifth Anniversary”), and (b)
prior to the Fifth Anniversary, the holders of a majority of the then outstanding Preferred Shares
have requested that the Company redeem all of the Preferred Shares in accordance with the
Memorandum and Articles, the holders of a majority of the then outstanding Preferred Shares, voting
separately from the Ordinary Shares as a single class, shall have the right to designate one or
more Preferred Directors to replace such number of Ordinary Directors so that a majority of the
Board of Directors will be Preferred Directors. The mandate of the Preferred Directors so elected
is to seek a Sale of the Company promptly.

          (iii) In the event that (a) redemption of the Preferred Shares or a Qualified IPO has not
occurred prior to the Fifth Anniversary, and (b) on or after the Fifth Anniversary, (x) the holders
of a majority of the then outstanding Preferred Shares for the first time request that the Company
redeem all of the Preferred Shares in accordance with the Memorandum and Articles, and (y) such
redemption does not occur within ninety (90) days following such request, the holders of a majority
of the then outstanding Preferred Shares, voting separately from the Ordinary Shares as a single
class, from and after such ninetieth (90th) day, shall have the right to designate one
or more Preferred Directors to replace such number of Ordinary Directors so that a majority of the
Board of Directors will be Preferred Directors. The mandate of the Preferred Directors so elected
is to seek a Sale of the Company promptly.

          (iv) In the event that the Company fails to pay dividends on the Preferred Shares in cash for
any two (2) consecutive fiscal quarters following September 15, 2009 in accordance with the
Memorandum and Articles, the holders of a majority of the then outstanding Preferred Shares, voting
separately from the Ordinary Shares as a single class, shall have the right to designate two (2)
additional Preferred Directors to the Board and the size of the Board shall be correspondingly
increased by two (2). Such appointment rights shall cease at such time as the Company has paid
dividends on the Preferred Shares in cash for four (4) consecutive fiscal quarters. The Company
will reimburse such directors so appointed for reasonable expenses incurred in attending all Board
meetings.

          (v) At each election of the directors of the Board, each holder of Ordinary Share Equivalents
shall vote at any meeting of members, such number of Ordinary Share Equivalents (on an as-converted
basis) as may be necessary, or in lieu of any such meeting, shall give such holder’s written
consent, as the case may be, with respect to such number of Ordinary Share Equivalents (on an
as-converted basis) (a) as may be necessary to elect as the Preferred Directors the individuals
designated by the Series A and Series B Lead Investor and/or the holders of a majority of the then
outstanding Preferred Shares, as the case may be,

25

 

and (b) against any other Preferred Director nominee not so designated by the Series A and Series B
Lead Investor or the holders of a majority of the then outstanding Preferred Shares.

          (vi) At each election of the directors of the Board, each holder of Ordinary Share Equivalents
shall vote at any meeting of members, such number of Ordinary Share Equivalents (on an as-converted
basis) as may be necessary, or in lieu of any such meeting, shall give such holder’s written
consent, as the case may be, with respect to such number of Ordinary Share Equivalents (on an
as-converted basis) (a) as may be necessary to elect as the Ordinary Directors the individuals
designated by the holders of a majority of the then outstanding Ordinary Shares and (b) against any
other Ordinary Director nominee not so designated. The Ordinary Directors shall initially be John
Kuhns, Richard Hochman, Anthony Dixon, Stephen Outerbridge, Shad Stastney and You-su Lin.

          (vii) Any holders of Ordinary Share Equivalents of the Company entitled to designate any
individual to be elected as a director of the Board pursuant to this Section
11.1(including, in the case of the Ordinary Directors, the Founders) shall have the right to
remove any director occupying such position (including a director appointed pursuant to clause
11.1(viii) below) and to fill any vacancy caused by the resignation, death or renewal of any
director occupying such position.

          (viii) Any director not elected in the manner provided in sub-paragraphs (i), (ii), (iii) or
(iv) shall be elected by the members at a general meeting, with holders of Preferred Shares and
Ordinary Shares voting together on an as-converted basis and not as separate classes, provided that
the directors shall have power at any time and from time to time to appoint any person to be such a
director in order to fill a casual vacancy on the Board.

     11.2 Alternates. Subject to applicable Law, a Preferred Director shall be entitled to appoint
an alternate to serve at any Board meeting, and such alternate shall be permitted to attend all
Board meetings and vote on behalf of the Preferred Director for whom she or he is serving as an
alternative.

     11.3 Committees. From immediately after the Closing, and until such time as the Board
(including the Preferred Directors or any Board Observers designated pursuant to Section
11.8(i) in the event any holder or holders of Preferred Shares elect not to designate a
Preferred Director such holder(s) have the right to designate, if any) shall decide otherwise, the
Company shall have and maintain (i) a compensation committee (the “Compensation Committee”) of no
fewer than three (3) directors and no more than five (5) directors, and (ii) an audit committee
(the “Audit Committee”) of no fewer than three (3) directors and no more than five (5) directors.
Each such committee shall have such powers and responsibilities as the Board (including the
Preferred Directors or any Board Observers designated pursuant to Section 11.8(i) in the
event any holder or holders of Preferred Shares elect not to designate a Preferred Director such
holder(s) have the right to designate, if any) shall determine. The Company shall ensure that at
all times a majority of the members of each such committee are independent directors and that none
of the members of each such committee shall be employees or members of the management of any member
of the Company Group; provided, that if there are insufficient independent directors on the
Board to constitute a majority of directors on any committee, then all independent directors shall
serve on such committee; provided further that each Preferred Directors (or Board
Observers designated pursuant to Section 11.8(i) in the event any holder or holders of
Preferred Shares elect not to designate a Preferred Director such holder(s) have the right to
designate) shall have the right, but not the obligation, to serve as a member on any committee.

26

 

     11.4 D&O Insurance. The Company shall purchase and maintain directors’ and officers’
insurance from a carrier and in an amount as shall be agreed by the Board (including all Preferred
Directors or any Board Observers designated pursuant to Section 11.8(i) in the event any
holder or holders of Preferred Shares elect not to designate a Preferred Director such holder(s)
have the right to designate, if any), provided that such insurance coverage is available at
commercially reasonable rates as determined by the Board (including all Preferred Directors or any
Board Observers designated pursuant to Section 11.8(i) in the event any holder or holders
of Preferred Shares elect not to designate a Preferred Director such holder(s) have the right to
designate, if any), in relation to any person who is or was a director or an officer of the
Company, or who at the request of the Company is or was serving as a director or an officer of, or
in any other capacity is or was acting for, another company or a partnership, joint venture, trust
or other enterprise, against any liability asserted against the person and incurred by the person
in that capacity. The Memorandum and Articles shall at all times provide that the Company shall
indemnify the members of the Company’s Board to the maximum extent permitted by the Law of the
jurisdiction in which the Company is organized.

     11.5 Assignment. Regardless of anything else contained herein, the rights of the Investors
under this Section 11 are non-transferable and non-assignable (including without limitation
by operation of law), except in connection with a transfer of Preferred Shares by any Investor to
its Affiliates, in which case such rights shall be transferable but only to the extent applicable
to such transferred Preferred Shares.

     11.6 Amendment. So long as the Investors hold any Preferred Shares, no right of the Investors
under this Section 11 may be amended or waived (either generally or in a particular
instance and either retroactively or prospectively) without the written consent of the Series A and
Series B Lead Investor and Investors representing at least two thirds (2/3) of the aggregate voting
power of the Equity Securities held by all of the Investors.

     11.7 Board Meetings. The Company shall use its reasonable best efforts to hold no less than
one (1) Board meeting during each fiscal quarter. A quorum for a Board meeting shall consist of a
majority of the then current Directors, provided that such majority includes all the then current
Preferred Directors (or any Board Observers designated pursuant to Section 11.8(i) in the event any
holder or holders of Preferred Shares elect not to designate a Preferred Director such holder(s)
have the right to designate, if any). If at the time specified for a Board meeting a quorum is not
present as a result of the absence of one or more Preferred Directors or any Board Observers
designated pursuant to Section 11.8(i), as the case may be, such meeting shall stand
adjourned until the same day and time at the same place in the following week. At any such
adjourned meeting, a majority of the then current Directors shall constitute a quorum, regardless
of whether any Preferred Director is present.

     11.8 Board Observer.

          (i) Notwithstanding any other provisions in this Section 11, for so long as CPI
Ballpark Investments Ltd. or any of its Affiliates, taken together, hold any Preferred Shares or
hold Ordinary Shares representing at least 5% of the then outstanding Ordinary Shares issued upon
conversion of the Preferred Shares, CPI Ballpark Investments Ltd. (or an Affiliate of CPI Ballpark
Investments Ltd. to whom CPI Ballpark Investments Ltd. has delegated in writing its rights pursuant
to this Section 11.8) shall be entitled to designate a Board observer (the “Board
Observer”) to attend all meetings of the Board in a non-voting observer capacity (except where the
consent of any Board Observer is required by this Agreement).

27

 

          (ii) Notwithstanding any other provisions in this Section 11, Aqua Resources Fund
Limited (or an Affiliate of Aqua Resources Fund Limited to whom Aqua Resources Fund Limited has
delegated in writing its rights hereunder) shall be entitled to designate a Board observer to
attend all meetings of the Board in a non-voting observer capacity only.

          (iii) All of the notification, background information, resolution, plans and schedules
relating to the Board meetings shall be delivered to the Board observer under the same notification
requirements as applicable to the Preferred Directors; provided, however, that the
Board observer shall agree to hold in confidence and trust and to act in a fiduciary manner with
respect to all information so provided.

          (iv) The rights set forth in Section 11.8 shall terminate and be of no further force
or effect upon the closing of a Qualified IPO.

12. Additional Agreements; Covenants; Protective Provisions.

     12.1 Initial Public Offering. The Company shall use commercially reasonable efforts to cause
a Qualified IPO to occur by March 31, 2010.

     12.2 Use of Proceeds. The Company shall use the proceeds that it receives pursuant to the
Series C Preferred Share Purchase Agreement as follows: (i) to fund the Company’s future
acquisition of hydroelectric power generating assets and expansion of the Company’s existing
hydroelectric projects in the PRC on terms and pursuant to definitive documentation approved in
writing by the Series A and Series B Lead Investor; and (ii) for the Company’s working capital and
general corporate purposes provided that no dividends shall be paid by the Company from such
proceeds.

     12.3 Approval of Business Plan. The Parties to this Agreement shall ensure that an annual
budget and business plan (including any capital expenditure budget, operating budget and financing
plan) is presented to and approved by the Board, subject to Article 154 of the Memorandum and
Articles, before the beginning of each fiscal year; provided, that such annual budget and
business plan shall include a month-by-month breakdown of all estimated capital expenditure,
operating, financial and any other estimates included in such annual budget and business plan.

     12.4 Compliance.

          (i) The Company, each Founder and each Ordinary Shareholder shall cause each member of the
Company Group and use his, her or its best efforts to ensure that its directors, officers,
employees, agents and other persons acting on behalf of such company (the “Representatives”) shall
comply with all applicable Laws, including the FCPA and all anti-bribery, anti-corruption and
anti-money laundering Laws as referred to in Section 3.17 of each of the Series A Preferred
Share Purchase Agreement, the Series B Preferred Share Purchase Agreement and the Series C
Preferred Share Purchase Agreement and all Environmental Laws.

          (ii) The Company, each Founder and each Ordinary Shareholder shall cause each member of the
Company Group to promptly notify the Shareholders if any current or future Representatives of any
member of the Company Group are or become Public Officials.

28

 

          (iii) The Company, each Founder and each Ordinary Shareholder shall cause each member of the
Company Group to promptly notify the Shareholders if any member of the Company Group will conduct
or agrees to conduct any business, or enter into or agree to enter into any transaction with any
Person, in Iran, Myanmar, Sudan or Cuba, and shall not undertake any such transaction without the
prior written consent of the Series A and Series B Lead Investor and the holders of at least a
majority of the then outstanding Preferred Shares.

          (iv) The Company, each Founder and each Ordinary Shareholder shall cause each member of the
Company Group to promptly notify the Shareholders if any member of the Company Group is in breach
of any Environmental Law.

     12.5 Board of Directors of Members of the Company Group. Subject to Section 12.9, the
Company, the Founders and the Ordinary Shareholders shall ensure that the board of directors of
each member of the Company Group shall not have independent decision making power over their
respective entities, and that the Company shall have sole decision making power over all business
and affairs of any member of the Company Group.

     12.6 Legend on Share Certificates. Each certificate representing any Shares issued after the
date hereof shall be endorsed by the Company with a legend reading substantially as follows:

“THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS. THEY MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION
STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER THE ACT OR AN OPINION OF
COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS
SOLD PURSUANT TO RULE 144 OF THE ACT.”

The Company, by its execution of this Agreement, agrees that it will cause the certificates
evidencing the Shares issued after the date hereof to bear the legend required by this Section
12.6 of this Agreement, and it shall supply, free of charge, a copy of this Agreement to any
holder of a certificate evidencing Shares upon written request from such holder to the Company at
its principal office. The parties to this Agreement do hereby agree that the failure to cause the
certificates evidencing the Shares to bear the legend required by this Section 12.6 herein
and/or the failure of the Company to supply, free of charge, a copy of this Agreement as provided
hereunder shall not affect the validity or enforcement of this Agreement.

     12.7 Employment Matters. The Company will, and the Founders and Ordinary Shareholders will
cause the Company to, cause each person now or hereafter employed by any member of the Company
Group (or engaged by any member of the Company Group as a consultant or independent contractor)
with access to confidential information and/or trade secrets to enter into a nondisclosure and
proprietary rights assignment agreement in form and substance satisfactory to the Series A and
Series B Lead Investor.

     12.8 Successor Indemnification. If the Company or any of its successors or assignees
consolidates with or merges into any other Person and is not the continuing or surviving
corporation or entity of such consolidation or merger, then to the extent necessary, proper
provision shall be made so that the successors and assignees of the Company
assume the

29

 

obligations of the Company with respect to indemnification of members of the Board of Directors as
in effect immediately before such transaction, whether such obligations are contained in the
Memorandum and Articles, or elsewhere, as the case may be.

     12.9 Protective Provisions. In addition to such other limitations as may be provided in the
Memorandum and Articles, the Founders, the Investors and the Ordinary Shareholders in their
capacity as shareholders (and not directors) and the Company solely in respect of other members of
the Company Group and not itself agree to do all such things and to take all such actions
(including by voting equity securities of the Company held by them and, in respect of the Founders
and Ordinary Shareholders only, by procuring the votes of directors designated by them) to procure
that neither the Company nor any member of the Company Group shall undertake any of the actions set
out in (i) to (xxii) below without the written consent of all Preferred Directors (except that in
the event any holder or holders of Preferred Shares elect not to designate a Preferred Director
such holder(s) have the right to designate, then the consent of any Board Observer designated
pursuant to Section 11.8(i), if any, shall be required). To the extent permitted by
applicable Law, the Company agrees as regards itself (and not other members of the Company Group)
not to take any of the actions set out in (i) to (xxii) below without the written consent of all
Preferred Directors (except that in the event any holder or holders of Preferred Shares elect not
to designate a Preferred Director such holder(s) have the right to designate, then the consent of
any Board Observer designated pursuant to Section 11.8(i), if any, shall be required)
(provided, however, that none of the foregoing provisions shall be deemed to require the approval
of the Preferred Director or the Board Observer, as the case may be, with respect to any action
permitted by the Annual Capital Budget or any deminimus action which is reasonably required to
implement any action for which approval is not required or has already been granted in accordance
with this Section 12.9):

          (i) Authorize or issue any additional, or additional series of, Preferred Shares or any other
new class or series of equity securities or any securities convertible into equity securities of
the Company.

          (ii) Purchase, repurchase or redeem (a) Ordinary Shares, (b) securities or rights of any kind
convertible into or exercisable or exchangeable for Ordinary Shares or (c) other securities of the
Company (except (i) in the case of a termination of an employee, at which the Company may
repurchase or redeem such Ordinary Shares at cost and pursuant to any agreement under which such
Ordinary Shares were issued, or (ii) for redemption of the Preferred Shares in accordance with the
Memorandum and Articles).

          (iii) Enter into, or enter any binding agreement to enter into, any transaction which would,
upon consummation, constitute a Change-of-Control Event.

          (iv) Sell, mortgage, pledge, transfer, lease or otherwise dispose of 50% or more of its
consolidated assets (as shown on the most recent financial statements of any member of the Company
Group) in any single transaction or series of related transactions (other than the sale of
inventory in the ordinary course of business), or liquidate, dissolve, recapitalize or reorganize
in any form of transaction.

          (v) Effect any reclassification, combination or reverse stock split of the Ordinary Shares.

          (vi) Amend any article or provision of the Memorandum and Articles.

30

 

          (vii) Establish any Subsidiary or make any investment in any equity or equity-related
securities of any Person (other than an entity controlled by the Company), or enter into any joint
venture or partnership other than a strategic alliance not involving any equity or equity-related
investment.

          (viii) Incur any debt or any other financial obligations exceeding US$10,000,000;
provided, however, no approval shall be required in order for the Company and its
subsidiaries to maintain its current level of indebtedness.

          (ix) Make any capital expenditure or other purchase of tangible or intangible assets in any
fiscal year that in the aggregate (on a consolidated basis) exceeds US$1,000,000.

          (x) Acquire, through purchase, lease or rental any automobile or motor vehicle valued or
having a purchase price in excess of US$30,000 (other than vehicles used in the conduct of the
Company’s business with the purchase price for all such vehicles not to exceed US$300,000 in the
aggregate), or any real estate other than the office space occupied by the Company and its
Subsidiaries as of the date of this Agreement.

          (xi) Make any decision with respect to the prosecution or settlement of legal actions, where
the aggregate amount of all claims so prosecuted or settled would exceed US$1,000,000 within any
fiscal year.

          (xii) Change the domicile of any member of the Company Group.

          (xiii) Change the external auditor to a Person which is not one of the Big-4 accounting firms
or any material changes to the accounting methods or policies of any member of the Company Group.

          (xiv) Enter into any transaction or agreement with a Related Party which is outside of the
ordinary course of business, or material or not on an arm’s length basis.

          (xv) Determine the timing and valuation of any IPO of the securities of the Company that is
not a Qualified IPO, the securities exchange on which such securities shall be listed and the lead
book-runner for such listing.

          (xvi) Make any change in the Company’s name or any material change in the primary business of
any member of the Company Group, the addition of any new business to any member of the Company
Group, the termination of any material existing business of any member of the Company Group.

          (xvii) Make any material amendment or change to the employment and / or employment terms of
any Key Employee.

          (xviii) Increase the authorized number of directors of any member of the Company Group.

          (xix) License or transfer any of patents, copyrights, trademarks or other intellectual
property of any member of the Company Group which are material to the operations of the Company
Group other than in the ordinary course of its business.

31

 

          (xx) File for winding up, bankruptcy, dissolution or liquidation with respect to any member of
the Company Group (including any Liquidation Event, as such term is defined herein).

          (xxi) Approve or adopt any annual capital expenditure budget (the “Annual Capital Budget”) and
any amendment to a previously approved or adopted Annual Capital Budget; provided, that approved or
adopted Annual Capital Budget must be approved in accordance with this clause (xxi) prior to the
commencement of business operations in the relevant fiscal year and provided further that such
first Annual Capital Budget shall include a budget item for up to US$75 million for future
acquisitions of hydroelectric assets in the PRC.

          (xxii) Agree to undertake to do any of the foregoing.

13. Assignments and Transfers; No Third Party Beneficiaries. Except as otherwise provided herein,
this Agreement and the rights and obligations of the parties hereunder shall inure to the benefit
of, and be binding upon, their respective successors, assigns and legal representatives, but shall
not otherwise be for the benefit of any third party. The rights of any Holder hereunder
(including, without limitation, registration rights) are assignable in connection with the transfer
(subject to Applicable Securities Laws and other Laws) of Equity Securities held by such Holder but
only to the extent of such transfer. This Agreement and the rights and obligations of any party
hereunder shall not otherwise be assigned without the mutual written consent of the other parties;
provided that each Investor may assign its rights and obligations to an Affiliate of such Investor
without consent of the other parties under this Agreement.

14. Liquidation.

     14.1 Liquidation Preferences. Subject to Section 14.2, upon any liquidation of the
Company, whether voluntary or involuntary:

          (i) Before any distribution or payment shall be made to the holders of any Ordinary Shares,
each holder of Series A Preferred Shares, Series B Preferred Shares or Series C Preferred Shares
shall be entitled to receive an amount equal to one hundred percent (100%) of the applicable
Original Preferred Issue Price (As Adjusted), plus all dividends declared and unpaid with respect
thereto per Preferred Share then held by such holder. If, upon any such liquidation, the assets of
the Company shall be insufficient to make payment of the foregoing amounts in full on all Preferred
Shares, then such assets shall be distributed among the holders of all Preferred Shares, ratably in
proportion to the full amounts to which they would otherwise be respectively entitled thereon.

          (ii) After distribution or payment in full of the amount distributable or payable pursuant to
Section 14.1(i), the remaining assets of the Company available for distribution shall be
distributed ratably among the holders of outstanding Shares.

     14.2 Liquidation on Sale or Merger. The following events shall be treated as a liquidation
(each, a “Liquidation Event”) under Section 14.1 unless waived by the Series A and Series B
Lead Investor: (i) any liquidation, winding-up, or dissolution of the Company, (ii) any merger or
consolidation of the Company or any other transaction or series of transactions, as a result of
which the shareholders of the Company immediately prior to such transaction or series of
transactions will cease to own a majority of the Equity Securities or voting power of the surviving
entity immediately following the consummation of such transaction or series of

32

 

transactions, (iii) the sale of all or substantially all of the assets of any member of the Company
Group (including the licenses and permits necessary to conduct the business of the Company in the
PRC) to or from a third party unaffiliated with any member of the Company Group, or (iv) the
transfer (whether by merger, reorganization or other transaction) in which a majority of the
outstanding voting power of the Company is transferred (excluding any sale undertaken upon exercise
of the rights set forth in Section 9 or any sale of Shares by the Company for capital
raising purposes). In the event of a Liquidation Event pursuant to clauses (ii), (iii) or (iv)
above, the distribution to be effected pursuant to Section 14.1 shall be made by share
capital reduction, dividend, repurchase or redemption of the Preferred Shares or in other lawful
manner as determined by the Board of Directors. The Parties agree to procure that all necessary
actions, including the passing of any necessary or expedient shareholder or Board resolutions, are
taken to give effect to this Section 14.2.

15. Miscellaneous.

     15.1 Governing Law. This Agreement shall be governed by and construed under the Laws of the
State of New York, without regard to principles of conflicts of law thereunder.

     15.2 Dispute Resolution.

          (i) Any dispute, controversy or claim (each, a “Dispute”) arising out of or relating to this
Agreement, or the interpretation, breach, termination or validity hereof, shall be resolved at the
first instance through consultation between the parties to such Dispute. Such consultation shall
begin immediately after any party has delivered written notice to any other party to the Dispute
requesting such consultation.

          (ii) If the Dispute is not resolved within thirty (30) days following the date on which such
notice is given, the Dispute shall be submitted to arbitration upon the request of any party to the
Dispute with notice to each other party to the Dispute (the “Arbitration Notice”).

          (iii) The arbitration shall be conducted in Hong Kong and shall be administered by the Hong
Kong International Arbitration Centre (“HKIAC”) in accordance with the HKIAC Procedures for the
Administration of International Arbitration in force at the time of the commencement of the
arbitration. There shall be three (3) arbitrators. The claimants in the Dispute shall
collectively choose one arbitrator, and the respondents shall collectively choose one arbitrator.
The Secretary General of the Centre shall select the third arbitrator, who shall be qualified to
practice law in the State of New York. If any of the members of the arbitral tribunal have not
been appointed within thirty (30) days after the Arbitration Notice is given, the relevant
appointment shall be made by the Secretary General of the Centre.

          (iv) The arbitration proceedings shall be conducted in English. The arbitration tribunal
shall apply the Arbitration Rules of the United Nations Commission on International Trade Law, as
in effect at the time of the commencement of the arbitration. However, if such rules are in
conflict with the provisions of this Section 15.2, including the provisions concerning the
appointment of arbitrators, the provisions of this Section 15.2 shall prevail.

          (v) Each party to the arbitration shall cooperate with each other party to the arbitration in
making full disclosure of and providing complete access to all information and

33

 

documents relevant to the arbitration proceedings and reasonably requested by such other party in
connection with such arbitration proceedings, subject only to any confidentiality obligations
binding on such party.

          (vi) The arbitrators shall decide any dispute submitted by the parties to the arbitration
tribunal strictly in accordance with the substantive law of the State of New York and shall not
apply any other substantive law.

          (vii) Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if
possible, from any court of competent jurisdiction.

          (viii) The Parties to this Agreement agree to the consolidation of arbitrations arising out of
or in connection with this Agreement or any of the Transaction Documents in accordance with the
provisions of this Section 15.2.

(a) In the event of two or more arbitrations having been commenced arising out of or
in connection with this Agreement or any of the Transaction Documents, the tribunal
in the arbitration first filed (the “Principal Tribunal”) may in its sole
discretion, upon the application of any party to the arbitrations, order that the
proceedings be consolidated before the Principal Tribunal if (1) there are issues of
fact and/or law common to the arbitrations, (2) the interests of justice and
efficiency would be served by such a consolidation, and (3) no prejudice would be
caused to any party in any material respect as a result of such consolidation,
whether through undue delay or otherwise. Such application shall be made as soon as
practicable and the party making such application shall give notice to the other
parties to the arbitrations.

(b) The Principal Tribunal shall be empowered to (but shall not be obliged to) order
at its discretion, after inviting written (and where desired by the Principal
Tribunal oral) representations from the parties that all or any of such arbitrations
shall be consolidated or heard together and/or that the arbitrations be heard
sequentially and shall establish a procedure accordingly. All parties shall take
such steps as are necessary to give effect and force to any orders of the Principal
Tribunal.

(c) If the Principal Tribunal makes an order for consolidation, it: (1) shall
thereafter, to the exclusion of other arbitral tribunals, have jurisdiction to
resolve all disputes forming part of the consolidation order; (2) shall order that
notice of the consolidation order and its effect be given immediately to any
arbitrators already appointed in relation to the disputes consolidated under the
consolidation order; and (3) may also give such directions as it considers
appropriate (i) to give effect to the consolidation and make provision for any costs
which may result from it (including costs in any arbitration rendered functus
officio under Section 15.2); and (ii) to ensure the proper organization of
the arbitration proceedings and that all the issues between the parties are properly
formulated and resolved.

(d) Upon the making of the consolidation order, any appointment of arbitrators
relating to arbitrations that have been consolidated by the Principal Tribunal
(except for the appointment of the arbitrators of the Principal Tribunal itself)
shall for all purposes cease to have effect and such arbitrators are deemed

34

 

to be functus officio, on and from the date of the consolidation order. Such
cessation is without prejudice to (1) the validity of any acts done or orders made
by such arbitrators before termination, (2) such arbitrators’ entitlement to be paid
their proper fees and disbursements and (3) the date when any claim or defence was
raised for the purpose of applying any limitation period or any like rule or
provision.

(e) The Parties hereby waive any objections they may have as to the validity and/or
enforcement of any arbitral awards made by the Principal Tribunal following the
consolidation of disputes or arbitral proceedings in accordance with this
Section 15.2 where such objections are based solely on the fact that
consolidation of the same has occurred.

          (ix) During the course of the arbitration tribunal’s adjudication of the dispute, this
Agreement shall continue to be performed except with respect to the part in dispute and under
adjudication.

          (x) The award of the arbitration tribunal shall be final and binding upon the parties, and the
prevailing party may apply to a court of competent jurisdiction for enforcement of such award.

     15.3 Counterparts. This Agreement may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same
instrument. Facsimile and e-mailed copies of signatures shall be deemed to be originals for
purposes of the effectiveness of this Agreement.

     15.4 Notices. Any notice required or permitted pursuant to this Agreement shall be given in
writing and shall be given either personally or by sending it by next-day or second-day courier
service, fax, electronic mail or similar means to the address as shown below the signature of such
party on the signature page of this Agreement (or at such other address as such party may designate
by fifteen (15) days’ advance written notice to the other parties to this Agreement given in
accordance with this Section). Where a notice is sent by next-day or second-day courier service,
service of the notice shall be deemed to be effected by properly addressing, pre-paying and sending
by next-day or second-day service through an internationally-recognized courier a letter containing
the notice, with a confirmation of delivery, and to have been effected at the expiration of two
days after the letter containing the same is sent as aforesaid. Where a notice is sent by fax or
electronic mail, service of the notice shall be deemed to be effected by properly addressing, and
sending such notice through a transmitting organization, with a written confirmation of delivery,
and to have been effected on the day the same is sent as aforesaid.

     15.5 Headings and Titles. Headings and titles used in this Agreement are used for convenience
only and are not to be considered in construing or interpreting this Agreement.

     15.6 Expenses. If any action at law or in equity is necessary to enforce or interpret the
terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees,
costs and necessary disbursements in addition to any other relief to which such party may be
entitled.

     15.7 Amendments and Waivers. Any term of this Agreement may be amended and the observance of
any term of this Agreement may be waived (either generally or in a particular

35

 

instance and either retroactively or prospectively), only with the written consent of each of (i)
the Company, (ii) holders holding at least a majority of the then outstanding Ordinary Shares,
(iii) holders holding at least two thirds (2/3) of the then outstanding Series A Preferred Shares,
Series B Preferred Shares and Series C Preferred Shares (voting as a single class), and (iv) the
Series A and Series B Lead Investor; provided, that if any amendment or waiver would have a
material and adverse impact on any individual shareholder of the Company (as compared to the other
shareholders of the Company) or any class of Equity Securities of the Company (as compared to any
other class of Equity Securities of the Company), then such amendment or waiver shall require the
written consent of such individual shareholder or of at least two thirds (2/3) of the aggregate
voting power of such class of Equity Securities, as the case may be. Any amendment or waiver
effected in accordance with this paragraph shall be binding upon each of the Parties hereto. The
Original Shareholders Agreement has been amended in accordance with Section 15.7 of the Original
Shareholders Agreement; and the Original Shareholders Agreement is hereby amended and restated and
this Amended and Restated Shareholders Agreement replaces the Original Shareholders Agreement. The
Parties agree, notwithstanding any other provisions of this Agreement, any amendment of the terms
of the Series A Preferred Shares and/or the Series B Preferred Shares shall not require the consent
or agreement of the holders of the Series C Preferred Shares unless such amendment will adversely
affect the existing rights and obligations of the holders of the Series C Preferred Shares.

     15.8 Additional Investors. Notwithstanding anything to the contrary contained herein, if the
Company issues additional shares of the Company’s Series A Preferred Shares, Series B Preferred
Shares or Series C Preferred Shares after the date hereof, whether pursuant to the Series A Share
Purchase Agreement, Series B Share Purchase Agreement, Series C Share Purchase Agreement or
otherwise, any purchaser of such shares of Preferred Shares shall become a party to this Agreement
by executing and delivering an additional counterpart signature page to this Agreement as a Series
A Investor, Series B Investor or Series C Investor, and thereafter shall be deemed a Series A
Investor, Series B Investor or Series C Investor for all purposes hereunder. No action or consent
by the Investors shall be required for such joinder to this Agreement by such additional Investor,
so long as such additional Investor has agreed in writing to be bound by all of the obligations as
a Series A Investor, Series B Investor or Series C Investor hereunder.

     15.9 Warrant Holders. If any Warrant Holder exercises its rights under relevant warrants and
consequently acquires any Ordinary Shares of the Company after the date hereof, such Warrant Holder
shall remain a party to this Agreement and be deemed an “Ordinary Shareholder” for all purposes
hereunder immediately upon the issuance of any Ordinary Shares to such Warrant Holder.

     15.10 Severability. If a provision of this Agreement is held to be unenforceable under
applicable Laws, such provision shall be excluded from this Agreement and the balance of the
Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in
accordance with its terms.

     15.11 Successors and Assigns. Except as otherwise provided herein, the terms and conditions
of this Agreement shall inure to the benefit of and be binding upon the respective successors and
assigns of the parties hereto whose rights or obligations hereunder are affected by such terms and
conditions. This Agreement, and the rights and obligations hereunder, shall not be assigned
without the mutual written consent of the parties hereto, provided that each Investor may assign
its rights and obligations to an Affiliate of such Investor without consent of

36

 

the other parties under this Agreement. Nothing in this Agreement, express or implied, is intended
to confer upon any party other than the parties hereto or their respective successors and assigns
any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as
expressly provided in this Agreement.

     15.12 Rights Cumulative. Each and all of the various rights, powers and remedies of a party
hereto will be considered to be cumulative with and in addition to any other rights, powers and
remedies which such party may have at law or in equity in the event of the breach of any of the
terms of this Agreement. The exercise or partial exercise of any right, power or remedy will
neither constitute the exclusive election thereof nor the waiver of any other right, power or
remedy available to such party.

     15.13 No Waiver. Failure to insist upon strict compliance with any of the terms, covenants,
or conditions hereof will not be deemed a waiver of such term, covenant, or condition, nor will any
waiver or relinquishment of, or failure to insist upon strict compliance with, any right, power or
remedy hereunder at any one or more times be deemed a waiver or relinquishment of such right, power
or remedy at any other time or times.

     15.14 No Presumption. The parties acknowledge that any applicable Law that would require
interpretation of any claimed ambiguities in this Agreement against the party that drafted it has
no application and is expressly waived. If any claim is made by a party relating to any conflict,
omission or ambiguity in the provisions of this Agreement, no presumption or burden of proof or
persuasion will be implied because this Agreement was prepared by or at the request of any party or
its counsel.

     15.15 No Conflict with Memorandum and Articles. In the event that the provisions of this
Agreement conflict with any provision of the Memorandum and Articles, the provisions of this
Agreement shall prevail and each of the Parties shall do all things and shall take all actions
(including voting shares and procuring directors to vote) as may reasonably be necessary to amend
the Memorandum and Articles in such manner as the Company and the Series A and Series B Lead
Investor are advised by Cayman Islands counsel will remove such conflict and give effect to the
provisions of this Agreement to the fullest extent permitted by law.

     15.16 Delays or Omissions.
No delay or omission to exercise any right, power or remedy accruing to any party under this
Agreement, upon any breach or default of any other party under this Agreement, shall impair any
such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed
to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar
breach or default thereafter occurring; nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver,
permit, consent or approval of any kind or character on the part of any party of any breach or
default under this Agreement, or any waiver on the part of any party of any provisions or
conditions of this Agreement, must be in writing and shall be effective only to the extent
specifically set forth in such writing. All remedies, either under this Agreement or by law or
otherwise afforded to any party, shall be cumulative and not alternative.

     15.17 Entire Agreement. This Agreement (including the Exhibits hereto) constitutes the full
and entire understanding and agreement among the parties with regard to the subjects hereof and
thereof, and supersedes all other agreements between or among any of the parties with respect to the subject matter hereof. After the execution and delivery of
this Agreement,

37

 

to the extent that there is any conflict between this Agreement and any provision of any other
agreement, arrangement or understanding between the Company and any holder of equity securities of
the Company, the terms and conditions of this Agreement shall prevail.

     15.18 Further Instruments and Actions. The Founders and Ordinary Shareholders agree to
execute such further instruments and to take such further action as may reasonably be necessary to
carry out the intent of this Agreement (including voting shares and procuring directors to vote).
The Founders and Ordinary Shareholders agree to cooperate affirmatively with the Company and the
Investors, to the extent reasonably requested by the Company or any Investor, to enforce rights and
obligations pursuant hereto.

[Signature Pages Follow.]

38

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	COMPANY: 	 CHINA HYDROELECTRIC CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	John D. Kuhns 	 
	 	 	Capacity: President and CEO
 	 
	 	 	
Address:  	
420 Lexington Avenue 
Suite 860 
New York, NY 10170
	 
	 	 	Fax:  	212-467-9800 	 

 

 

	 	 	 	 	 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	FOUNDERS: 	JOHN KUHNS

 	 
	 	
 	 
	 	Address: c/o China Hydroelectric Corporation 	 
	 	 	 
	 
	 	JAMES TIE LI

 	 
	 	
 	 
	 	Address: c/o China Hydroelectric Corporation 	 
	 	 	 
	 
	 	MARY FELLOWS

 	 
	 	
 	 
	 	Address: c/o China Hydroelectric Corporation 	 
	 	 	 
	 
	 	DR. YOU-SU LIN

 	 
	 	
 	 
	 	Address: c/o Beijing A.B.C. Investment Consulting Co., Ltd. 	 
	 	 	 

 

 

	 	 	 	 	 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	ORDINARY SHAREHOLDERS: 	VICIS CAPITAL MASTER FUND

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	CHINA HYDRO LLC

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

 

 

	 	 	 	 	 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	SERIES A INVESTOR:	 	 
	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	Address:  	 	 

 

 

	 	 	 	 	 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	SERIES B INVESTOR:	 	 
	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	Address:  	 	 

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	SERIES C INVESTOR:       	Aqua Resources Asia Holdings Limited

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	Address:  	 	 

 

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	WARRANT HOLDERS:       	JMG Triton Offshore Fund, Ltd.

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	Address:  	 	 
	 
	 	JMG Capital Partners, L.P.

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	Address:  	 	 
	 
	 	Morgan Joseph & Co. Inc.

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	Address:  	 	 
	 
	 	CHINA HYDRO LLC

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	VICIS CAPITAL MASTER FUND

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

 

 

EXHIBIT A(i)

SERIES C INVESTORS

Aqua Resources Asia Holdings Limited

 

 

EXHIBIT A(ii)

ORDINARY SHAREHOLDERS

1. Vicis Capital Master Fund

2. China Hydro LLC

 

 

EXHIBIT A(iii)

SERIES A INVESTORS

1.       CPI Ballpark Investments Ltd.

2.       Jennison Utility Fund

3.       Vicis Capital Master Fund

4.       Swiss Re Financial Products Corporation

5.       Citigroup Global Markets Inc.

6.       Sandelman Partners Multi-Strategy Master Fund, Ltd.

7.       HSBC GEM Common Fund

8.       HSBC Global Investment Fund — New World Income Fund

9.       Jayhawk Private Equity Co. — Invest Fund, LP

10.     Jayhawk Private Equity Fund, LP

11.     Rosebud Trust — Green

12.     AGE Trust — Green

13.     Kazak II Trust — Green

14.     Tehachapi Pass Trust — Green

15.     NISA Revocable Trust under Agreement Subaccount

16.     Radcliffe SPC, Ltd. (Class A Segregated Portfolio)

17.     Concordia Asia Pacific Multi-Strategy Master Fund LP

 

 

EXHIBIT A(iv)

SERIES B INVESTORS

1.       CPI Ballpark Investments Ltd.

2.       Jennison Utility Fund

3.       Vicis Capital Master Fund

4.       Swiss Re Financial Products Corporation

5.       Blue Ridge Investments, LLC

6.       China Environment Fund III, LP

7.       Abrax

8.       IWU International Ltd.

 

 

EXHIBIT A(V)

FOUNDERS

	 	 	 	 	 
	Name	 	 	 	ID/Passport Number
	1. John D. Kuhns

	 	[•]
	 	 
	2. James Tie Li

	 	[•]	 	 
	3. Mary Fellows

	 	[•]	 	 
	4. Dr. You-su Lin

	 	[•]	 	 

 

 

EXHIBIT A(vi)

WARRANT HOLDERS

1.     China Hydro, LLC

2.     Vicis Capital Master Fund

3.     JMG Triton Offshore Fund, Ltd.

4.     JMG Capital Partners, L.P.

5.     Morgan Joseph & Co. Inc.

 

 

EXHIBIT B

PFIC ANNUAL INFORMATION STATEMENT

[Must be signed by an authorized representative of the Company]

PFIC Annual Information Statement pursuant to U.S. Treasury Regulation §
1.1295-1(g).

                                         (the “Company”) hereby represents that:

	1.	 	This PFIC Annual Information Statement applies to the Company’s taxable
year beginning on                      and ending on                     .
	 
	2.	 	The pro rata shares of the Company’s ordinary earnings and net capital
gain attributable to the U.S. Shareholder (directly or indirectly through any
other entity that holds the investment in the Company) for the taxable year
specified in paragraph (1) are:
	 
	 	 	Ordinary Earnings: $                    
	 
	 	 	Net Capital Gain: $                     
	 
	3.	 	The amount of cash and the fair market value of other property
distributed or deemed distributed by the Company to the U.S. Shareholder
during the taxable year specified in paragraph (1) are as follows:
	 
	 	 	Cash: $       
                            
	 
	 	 	Fair Market Value of Property: $                                  
	 
	4.	 	The Company will permit the U.S. Shareholder to inspect the Company’s
permanent books of account, records, and such other documents as may be
maintained by the Company that are necessary to establish that the Company’s
ordinary earnings and net capital gain are computed in accordance with U.S.
Federal income tax principles, and to verify these amounts and the U.S.
Shareholders direct or indirect pro rata shares thereof; provided, that
(i) a Company representative shall, at the Company’s option, accompany the
Investor on any such inspection, and (ii) the Company shall not be required to
permit such inspection if such inspection would violate applicable Laws,
regulations or policies of the PRC or the Cayman Islands.

	 	 	 	 	 
	 	 	 
	By:  	
 	 	 
	 	Title: 	 	 
	 	Date:EX-4.5

Exhibit 4.5

CHINA HYDROELECTRIC CORPORATION

AMENDED AND RESTATED

RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT

 

 

AMENDED AND RESTATED 

RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT 

     THIS AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT (this “Agreement”) is
entered into as of October 27, 2009, by and among China Hydroelectric Corporation, a company duly
incorporated and validly existing under the Laws of the Cayman Islands (the “Company”), the
investors listed on Exhibit A(i) attached hereto (each, a “Series C Investor,”
collectively, the “Series C Investors”), the entities listed on Exhibit A(ii) attached
hereto (the “Ordinary Shareholders”), the entities listed on Exhibit A(iii) attached hereto
(the “Series A Investors”), the entities listed on Exhibit A(iv) attached hereto (the
“Series B Investors”), the individuals listed on Exhibit A(v) attached hereto (the
“Founders”), and the entities listed on Exhibit A(vi) attached hereto (the “Warrant
Holders”). The Company, the Series C Investors, the Ordinary Shareholders, the Series A Investors,
the Series B Investors, the Founders and the Warrant Holders are referred to herein collectively as
“Parties” and individually as a “Party.”

RECITALS

	A.	 	The Parties other than the Series C Investors entered into an Amended and Restated Right of
First Offer and Co-Sale Agreement dated as of July 24, 2008 (the “Original Right of First
Offer and Co-Sale Agreement”).
	 
	B.	 	The Company, each other member of the Company Group (as defined below) and the Series C
Investors have entered into a Series C Preferred Share Purchase Agreement dated as of even
date herewith (the “Series C Share Purchase Agreement”).
	 
	C.	 	It is a condition precedent under the Series C Share Purchase Agreement that the Original
Right of First Offer and Co-Sale Agreement be amended and restated in accordance with the
terms and conditions hereof.
	 
	D.	 	The parties desire to enter into this Agreement and to accept the rights, covenants and
obligations hereof.

WITNESSETH

     NOW, THEREFORE, in consideration of the premises set forth above, the mutual promises and
covenants set forth herein and other good and valuable consideration, the parties agree as follows:

1. Definitions. The following terms shall have the meanings ascribed to them below:

     “Affiliate” means, with respect to a Person, any other Person that, directly or
indirectly, Controls, is Controlled by or is under common Control with such Person.

     “Agreement” has the meaning set forth in Preamble of this Agreement.

     “Arbitration Notice” has the meaning set forth in Section 5.2(b) hereof.

     “Change-of-Control Event” means (i) any consolidation, amalgamation, scheme of
arrangement or merger of the Company with or into any other person or any other corporate
reorganization in which the members of the Company immediately prior to such consolidation,
amalgamation, merger, scheme of arrangement or

ROFO and Co-Sale Agreement

1

 

reorganization own less than a majority of the Company’s voting power immediately after
such consolidation, merger, amalgamation, scheme of arrangement or reorganization, or any
transaction or series of related transactions to which the Company is a party in which at
least a majority of the Company’s voting power is transferred; or (ii) a sale, transfer,
lease or other disposition of all or substantially all of the assets of the Company or of
the other members of the Company Group, taken as a whole (or any series of related
transactions resulting in such sale, transfer, or lease of all or substantially all of the
assets of the Company or of the other members of the Company Group, taken as a whole).

     “Company” has the meaning set forth in the Preamble of this Agreement.

     “Company Group” has the meaning set forth in the Series C Share Purchase Agreement.

     “Co-Sale Notice” has the meaning set forth in Section 2.3(a).

     “Co-Sale Transfer” has the meaning set forth in Section 2.3(a).

     “Control” of a given Person means the power or authority, whether exercised or not, to
direct the business, management and policies of such Person, directly or indirectly, whether
through the ownership of voting securities, by contract or otherwise, which power or
authority shall conclusively be presumed to exist upon possession of beneficial ownership or
power to direct the vote of more than fifty percent (50%) of the votes entitled to be cast
at a meeting of the members or shareholders of such Person or power to control the
composition of a majority of the board of directors of such Person; the term “Controlled”
has the meaning correlative to the foregoing.

     “Dispute” has the meaning set forth in Section 5.2(a) hereof.

     “Equity Securities” means any Ordinary Shares or Ordinary Share Equivalents of the
Company.

     “Exercising Shareholder” has the meaning set forth in Section 2.2(b)(iii)
hereof.

     “Founders” has the meaning set forth in the Preamble of this Agreement.

     “Governmental Authority” means any nation or government or any nation, province or
state or any other political subdivision thereof; any entity, authority or body exercising
executive, legislative, judicial, regulatory or administrative functions of or pertaining to
government, including any government authority, agency, department, board, commission or
instrumentality of any country, or any political subdivision thereof, any court, tribunal or
arbitrator, and any self-regulatory organization.

     “HKIAC” has the meaning set forth in Section 5.2(c) hereof.

     “Holders” means the Investors, together with the Permitted Transferees and assigns of
the Investors who become parties to this Agreement.

     “Investors” means the Series A Investors, Series B Investors and Series C Investors.

2

 

     “Key Employee” has the meaning set forth in the Memorandum and Articles.

     “Law” means any constitutional provision, statute or other law, rule, regulation,
official policy or interpretation of any Governmental Authority and any injunction,
judgment, order, ruling, assessment or writ issued by any Governmental Authority.

     “Liquidation Event” has the meaning given to such term in the Company’s Memorandum and
Articles of Association, as amended and restated from time to time.

     “Memorandum and Articles” has the meaning set forth in the Series C Share Purchase
Agreement.

     “Offered Shares” has the meaning set forth in Section 2.2(a) hereof.

     “Ordinary Shares” means the Company’s ordinary shares, with a par value of US$0.001 per
share.

     “Ordinary Share Equivalents” means warrants, options and rights exercisable for
Ordinary Shares or securities convertible into or exchangeable for Ordinary Shares,
including, without limitation, the Preferred Shares.

     “Ordinary Shareholders” has the meaning set forth in the Preamble of this Agreement.

     “Original Right of First Offer and Co-Sale Agreement” has the meaning set forth in the
Recitals of this Agreement.

     “Party” or “Parties” has the meaning set forth in the Preamble of this Agreement.

     “Permitted Transferee” means, with respect to a Person, (i) an Affiliate of such
Person; (ii) if such Person is a limited liability company or a limited or general
partnership, its members or partners, as the case may be, in connection with a distribution
of securities held by such Person to its members or partners; and (iii) if such Person is a
natural person, a trust for his or her benefit or for the benefit of his or her spouse or
issue or to a family partnership, limited liability company or similar entity of which the
members or partners are solely such Person, or such Person’s spouse or issue and as to which
such Person exercises all voting power.

     “Person” means any individual, corporation, partnership, limited partnership,
proprietorship, association, limited liability company, firm, trust, estate or other
enterprise or entity.

     “Preferred Shares” means the Series A Preferred Shares, the Series B Preferred Shares
and the Series C Preferred Shares.

     “Principal Tribunal” has the meaning set forth in Section 5.2(i) hereof.

     “Qualified IPO” has the meaning given to such term in the Amended and Restated Articles
of Association of the Company to be adopted in accordance with applicable Law on or before
the closing of the sale and purchase of the Series C Preferred Shares pursuant to the Series
C Share Purchase Agreement.

3

 

     “Re-allotment Period” has the meaning set forth in Section 2.2(b)(iii) hereof.

     “ROFO Option Period” has the meaning set forth in Section 2.2(b)(i) hereof.

     “Second Notice” has the meaning set forth in Section 2.2(b)(iii) hereof.

     “Series A and Series B Lead Investor” means CPI Ballpark Investments Ltd. or its
successor.

     “Series A Investors” has the meaning set forth in the Preamble of this Agreement.

     “Series A Preferred Shares” means the Series A Preferred Shares, par value of US$0.001
per share, issued by the Company pursuant to the Series A Share Purchase Agreement.

     “Series A Share Purchase Agreement” means the Share Purchase Agreement entered into by
and among the Company, each other then existing member of the Company Group, the Series A
Investors, the Founders on December 31, 2007.

     “Series A Transaction Documents” has the meaning set forth in the Series A Share
Purchase Agreement.

     “Series B Investors” has the meaning set forth in the Preamble of this Agreement.

     “Series B Preferred Shares” means the Series B Preferred Shares, par value of US$0.001
per share, issued by the Company pursuant to the Series B Share Purchase Agreement.

     “Series B Share Purchase Agreement” means the Share Purchase Agreement entered into by
and among the Company, each other then existing member of the Company Group and the Series B
Investors as of July 24, 2008.

     “Series B Transaction Documents” has the meaning of “Transaction Documents” set forth
in the Series B Share Purchase Agreement.

     “Series C Investors” has the meaning set forth in the Preamble of this Agreement.

     “Series C Preferred Shares” means the Series C Preferred Shares, par value of US$0.001
per share, to be issued by the Company pursuant to the Series C Share Purchase Agreement.

     “Series C Share Purchase Agreement” has the meaning set forth in the Recitals of this
Agreement.

     “Series C Transaction Documents” has the meaning of “Transaction Documents” set forth
in the Series C Share Purchase Agreement.

     “Selling Shareholders” has the meaning set forth in Section 2.3(b) hereof.

4

 

     “Transaction Documents” means the Series A Transaction Documents, the Series B
Transaction Documents and the Series C Transaction Documents.

     “Transfer” has the meaning set forth in Section 2.2(a) hereof.

     “Transfer Notice” has the meaning set forth in Section 2.2(a) hereof.

     “Transferor” has the meaning set forth in Section 2.2(a) hereof.

     “Warrant Holders” has the meaning set forth in the Preamble of this Agreement.

2. Rights of First Offer and Co-Sale Rights

     2.1 Restriction on Transfer of Shares.

          (a) Prohibition on Transfers prior to Qualified IPO. No Founder and no Ordinary Shareholder
that is or has been a Key Employee of any member of the Company Group, regardless of such holder’s
employment status with the Company, may transfer any direct or indirect interest in any Equity
Securities now or hereafter owned or held by him, her or it at any time prior to the earlier of (i)
completion of a Qualified IPO, (ii) the redemption by the Company of all Preferred Shares, (iii)
the consummation of a Change-of-Control Event, and (iv) written approval of any such transfer is
received from the Series A and Series B Lead Investor, or as permitted in Section 2.5
below.

          (b) Rights of First Offer & Co-Sale. Subject to Section 2.5, during the term of this
Agreement, no holder of Equity Securities of the Company, including without limitation the Holders,
may transfer any direct or indirect interest in any Equity Securities now or hereafter owned or
held by him, her or it except pursuant to the terms and conditions set forth in this Section
2.

          (c) Prohibited Transfers Void. Any transfer of Equity Securities not made in compliance with
this Agreement shall be null and void as against the Company, shall not be recorded on the books of
the Company and shall not be recognized by the Company.

     2.2 Right of First Offer.

          (a) Transfer Notice. If any holder of Equity Securities of the Company that is subject to
Section 2.1(b) above proposes to seek the sale or other transfer, directly or indirectly,
any Equity Securities (such holder, a “Transferor”) to one or more third parties (a “Transfer”),
then the Transferor shall give the Company and each Holder written notice of the Transferor’s
intention to seek the Transfer (the “Transfer Notice”), which shall include (i) a description of
the Equity Securities to be transferred (the “Offered Shares”), and (ii) the consideration and the
material terms and conditions upon which the proposed Transfer is to be made. The Transfer Notice
shall certify that the Transferor in good faith believes that a binding agreement for the Transfer
is obtainable on the terms set forth in the Transfer Notice.

          (b) Holders’ Option.

     (i) Each Holder other than the Transferor shall have an option for a period of twenty
(20) days following receipt of the Transfer Notice (the “ROFO Option Period”) to elect to
purchase all or any portion of its respective pro rata share (as

5

 

defined below) of the Offered Shares at the same price and subject to the same material
terms and conditions as described in the Transfer Notice, by notifying the Transferor and
the Company in writing before expiration of the ROFO Option Period as to the number of such
Offered Shares that it wishes to purchase.

     (ii) For the purposes of this Section 2.2(b), each Holder’s “pro rata share” of
the Offered Shares shall be equal to (i) the total number of Offered Shares multiplied by
(ii) a fraction, the numerator of which shall be the number of Equity Securities (assuming
the exercise, conversion and exchange of any Ordinary Share Equivalents) owned by such
Holder on the date of the Transfer Notice and the denominator of which shall be the total
number of Equity Securities (assuming the exercise, conversion and exchange of any Ordinary
Shares Equivalents) held by all Holders other than the Transferor on such date.

     (iii) If any Holder fails to exercise its right to purchase its full pro rata share of
the Offered Shares, the Transferor shall deliver written notice (the “Second Notice”) within
five (5) days after the expiration of the ROFO Option Period to the Company and each Holder
that elected to purchase its entire pro rata share of the Offered Shares (an “Exercising
Shareholder”). The Exercising Shareholders shall have a right of re-allotment, and may
exercise such additional right to purchase such unpurchased Offered Shares by notifying the
Transferor and the Company in writing within ten (10) days after receipt of the Second
Notice (the “Re-allotment Period”); provided, however, that if the
Exercising Shareholders desire to purchase in aggregate more than the number of such
unpurchased Offered Shares, then such unpurchased Offered Shares will be allocated to the
extent necessary among the Exercising Shareholders in accordance with their relative pro
rata shares, provided that no Exercising Shareholder shall be required to purchase a number
of unpurchased Offered Shares greater than such Exercising Shareholder has applied for.

     (iv) Subject to applicable securities Laws, each Holder shall be entitled to apportion
Offered Shares to be purchased among its Affiliates upon written notice to the Company and
the Transferor.

     (c) Procedure. If any Holder (a) gives the Transferor notice that it desires to
purchase Offered Shares, and, as the case may be, the exercise of its re-allotment, then
payment for the Offered Shares to be purchased shall be by check or wire transfer in
immediately available funds of the appropriate currency, against delivery of such Offered
Shares to be purchased at a place agreed to by the Transferor and all the participating
Holders and at the time of the scheduled closing therefor, which shall be no later than
thirty-five (35) days after receipt of the Transfer Notice by the Company and all Holders,
unless the value of the purchase price has not yet been established pursuant to Section
2.2(d). The Transferor shall have the right to terminate or withdraw any Transfer
Notice and any intent to transfer Offered Shares at any time prior to the election of any
Holder to purchase under this Section 2.2 any Offered Shares offered thereby.

     (d) Valuation of Property.

     (i) Should the purchase price specified in the Transfer Notice be payable in property
other than cash or evidences of indebtedness, the Holders shall have the right

6

 

to pay the purchase price in the form of cash equal in amount to the fair market value
of such property.

     (ii) If the Transferor and the Holders cannot agree on such cash value within the ROFO
Option Period, the valuation shall be made by an appraiser of internationally recognized
standing jointly selected by the Transferor and the Holders or, if they cannot agree on an
appraiser within the ROFO Option Period, each shall select an appraiser of internationally
recognized standing and the two appraisers shall designate a third appraiser of
internationally recognized standing, whose appraisal shall be determinative of such value.

     (iii) The cost of such appraisal shall be shared equally by the Transferor and the
Holders, with the fifty percent (50%) of the cost borne by the Holders to be borne pro rata
by each Holder that has elected to purchase Offered Shares based on the number of shares
such Holder has elected to purchase pursuant to this Section 2.2.

     (iv) If the value of the purchase price offered by the prospective transferee is not
determined within the thirty-five (35) day period specified in Section 2.2(c) above,
the closing of the sale of the Offered Shares shall be held on or prior to the fifth
(5th) business day after such valuation shall have been made pursuant to this
Section 2.2.

          (e) Subject to any other applicable restrictions on the sale of such shares, to the extent
that the Holders have not exercised their rights to purchase all Offered Shares within the time
periods specified in Section 2.2 the Transferor shall, subject to the right of co-sale set
forth in Section 2.3 below, have a period of sixty (60) days from the expiration of the
ROFO Option Period or the Re-allotment Period, as applicable, in which to identify and consummate
the sale of the remaining Offered Shares to one or more third party purchasers upon terms and
conditions (including the purchase price) no more favorable to the purchaser than those specified
in the Transfer Notice.

     2.3 Right of Co-Sale.

          (a) Co-Sale Notice. With respect to any proposed Transfer (other than to a Permitted
Transferee) by a Founder or Ordinary Shareholder, to the extent that the Holders have not exercised
their rights to purchase all Offered Shares with respect to such proposed Transfer within the time
periods specified in Section 2.2, if such Transferor shall identify one or more third party
purchasers and proposes to sell or transfer Offered Shares to such purchaser(s) pursuant to an
understanding with such third party purchaser(s) (a “Co-Sale Transfer”), then such Transferor shall
give the Company and each Holder that did not exercise its right of first offer with respect to
such Offered Shares pursuant to Section 2.2 written notice of such Transferor’s intention
to make the Co-Sale Transfer (the “Co-Sale Notice”), which shall include (i) a description of the
Offered Shares, (ii) subject to any applicable non-disclosure agreement with such third party
purchaser(s), the identity of the prospective purchaser(s), and (iii) the consideration and the
material terms and conditions upon which the proposed Co-Sale Transfer is to be made. The Co-Sale
Notice shall certify that the Founder or Ordinary Shareholder Transferor has received a definitive
offer from the prospective purchaser(s) and in good faith believes a binding agreement for the
Co-Sale Transfer is obtainable on the terms set forth in the Co-Sale Notice.

          (b) Each Holder that did not exercise its right of first offer with respect to such Offered
Shares pursuant to Section 2.2 shall have the right to participate in such sale of

7

 

Equity Securities on the same terms and conditions as specified in the Co-Sale Notice by
notifying the Founder or Ordinary Shareholder Transferor in writing within the twenty (20) day
period following receipt of the Co-Sale Notice (such Holder a “Selling Shareholder”). Such Selling
Shareholder’s notice to the Founder or Ordinary Shareholder Transferor shall indicate the number of
Equity Securities the Selling Shareholder wishes to sell under its right to participate. To the
extent one or more Holders exercise such right of participation in accordance with the terms and
conditions set forth below, the number of Equity Securities that the Transferor may sell in the
Founder or Ordinary Shareholder Transfer shall be correspondingly reduced proportionally.

          (c) The total number of Equity Securities that each Selling Shareholder may elect to sell
shall be equal to the product of (i) the aggregate number of the Offered Shares being transferred
following the exercise or expiration of all rights of first offer pursuant to Section 2.2
hereof, multiplied by (ii) a fraction, the numerator of which is the number of Equity Securities
(assuming the exercise, conversion and exchange of any Ordinary Shares Equivalents) owned by such
Selling Shareholder on the date of the Co-Sale Notice and the denominator of which is the total
number of Equity Securities (assuming the exercise, conversion and exchange of any Ordinary Shares
Equivalents) owned by the Transferor and all Selling Shareholders on the date of the Co-Sale
Notice.

          (d) Each Selling Shareholder shall effect its participation in the sale by promptly delivering
to the Company for transfer to the prospective purchaser one or more certificates and one or more
instruments of transfer, properly endorsed for transfer, which represent the type and number of
Equity Securities which such Selling Shareholder elects to sell; provided, however that if
the prospective third party purchaser(s) object to the delivery of Ordinary Share Equivalents in
lieu of Ordinary Shares, such Selling Shareholder shall only deliver Ordinary Shares (and therefore
shall convert any such Ordinary Share Equivalents into Ordinary Shares) and certificates
corresponding to such Ordinary Shares. The Company agrees to make any such conversion concurrent
with the actual transfer of such shares to the purchaser and contingent on such transfer.

          (e) Upon consummation of the sale of the Equity Securities pursuant to the terms and
conditions specified in the Co-Sale Notice, the Company shall issue one or more new share
certificates and shall update the register of members of the Company to reflect the sale to the
prospective purchaser(s) the type and number of Equity Securities which such Selling Shareholder
elects to sell pursuant to this Section 2.3, and the Founder or Ordinary Shareholder
Transferor shall concurrently therewith (and as a condition to such issuance of new share
certificates and update to the register of members of the Company) remit, or cause the prospective
purchaser(s) to remit, to such Selling Shareholder that portion of the sale proceeds to which such
Selling Shareholder is entitled by reason of its participation in such sale.

          (f) To the extent that any prospective purchaser prohibits the participation of a Selling
Shareholder exercising its co-sale rights hereunder in a proposed Co-Sale Transfer or otherwise
refuses to purchase shares or other securities from a Selling Shareholder exercising its co-sale
rights hereunder, the Founder or Ordinary Shareholder Transferor shall not sell to such prospective
purchaser any Equity Securities unless and until, simultaneously with such sale, the Founder or
Ordinary Shareholder Transferor shall purchase from such Selling Shareholder such shares or other
securities that such Selling Shareholder would otherwise be entitled to sell to the prospective
purchaser pursuant to its co-sale rights for the same consideration and on the same terms and
conditions as the proposed transfer described in the Co-Sale Notice.

8

 

     2.4 Non-Exercise of Rights.

          (a) In the event the Transferor does not consummate the sale or disposition of any Offered
Shares to one or more third party purchasers within sixty (60) days from the expiration of the ROFO
Option Period or the Re-Allotment Period, as applicable, the rights of the Holders under
Section 2.2 and Section 2.3, as the case may be, shall continue to be applicable to
any subsequent disposition of such Offered Shares by the Transferor until such rights lapse in
accordance with the terms of this Agreement.

          (b) The exercise or non-exercise of the rights of the Holders under this Section 2 to
purchase Equity Securities from a Transferor or participate in the sale of Equity Securities by a
Transferor shall not adversely affect their rights to make subsequent purchases from the Transferor
of Equity Securities or subsequently participate in sales of Equity Securities by the Transferor
hereunder.

     2.5 Limitations to Rights of First Offer and Co-Sale. Notwithstanding the provisions of this
Section 2, any sale, transfer or assignment to a Permitted Transferee shall not be subject
to Sections 2.1, 2.2 or 2.3, except as required by applicable Law;
provided that each such Permitted Transferee, prior to the completion of the sale,
transfer, or assignment, shall have executed a document in the form attached hereto as Exhibit
B assuming the obligations of its transferring party under this Agreement, including but not
limited to Section 2.1 hereof.

3. Assignments and Transfers; No Third Party Beneficiaries. Except as otherwise provided herein,
this Agreement and the rights and obligations of the Parties hereunder shall inure to the benefit
of, and be binding upon, their respective successors, assigns and legal representatives, but shall
not otherwise be for the benefit of any third party. Except as otherwise provided herein, the
rights of any Holder hereunder are only assignable in connection with the Transfer (subject to
applicable securities and other Laws) of Equity Securities held by such Holder but only to the
extent of such Transfer; provided, however, that (a) the Transferor shall, prior to
the effectiveness of such Transfer, furnish to the Company written notice of the name and address
of such Transferee and the Equity Securities that are being assigned to such Transferee, and (b)
such Transferee shall, concurrently with the effectiveness of such Transfer, become a Party to this
Agreement as an Ordinary Shareholder or Holder, as the case may be, and be subject to all
applicable restrictions set forth in this Agreement. This Agreement and the rights and obligations
of any Party hereunder shall not otherwise be assigned without the mutual written consent of the
other Parties.

4. Legend. Each existing or replacement certificate for Equity Securities now owned or hereafter
acquired by any holder thereof shall bear the following legend:

“THE SALE, PLEDGE, HYPOTHECATION, ASSIGNMENT OR TRANSFER OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS OF A RIGHT
OF FIRST OFFER AND CO-SALE AGREEMENT BY AND BETWEEN THE MEMBER, THE COMPANY AND
CERTAIN HOLDERS OF SHARES OF THE COMPANY. COPIES OF SUCH AGREEMENTS MAY BE
OBTAINED UPON WRITTEN REQUEST TO THE COMPANY.”

5. Miscellaneous

9

 

     5.1 Governing Law. This Agreement shall be governed by and construed under the Laws of the
State of New York without regard to conflicts of law provisions.

     5.2 Dispute Resolution.

          (a) Any dispute, controversy or claim (each, a “Dispute”) arising out of or relating to this
Agreement, or the interpretation, breach, termination or validity hereof, shall be resolved at the
first instance through consultation between the parties to such Dispute. Such consultation shall
begin immediately after any party has delivered written notice to any other party to the Dispute
requesting such consultation.

          (b) If the Dispute is not resolved within thirty (30) days following the date on which such
notice is given, the Dispute shall be submitted to arbitration upon the request of any party to the
Dispute with notice to each other party to the Dispute (the “Arbitration Notice”).

          (c) The arbitration shall be conducted in Hong Kong and shall be administered by the Hong Kong
International Arbitration Centre (“HKIAC”) in accordance with the HKIAC Procedures for the
Administration of International Arbitration in force at the time of the commencement of the
arbitration. There shall be three (3) arbitrators. The claimants in the Dispute shall
collectively choose one arbitrator, and the respondents shall collectively choose one arbitrator.
The Secretary General of the Centre shall select the third arbitrator, who shall be qualified to
practice law in New York. If any of the members of the arbitral tribunal have not been appointed
within thirty (30) days after the Arbitration Notice is given, the relevant appointment shall be
made by the Secretary General of the Centre.

          (d) The arbitration proceedings shall be conducted in English. The arbitration tribunal shall
apply the Arbitration Rules of the United Nations Commission on International Trade Law, as in
effect at the time of the commencement of the arbitration. However, if such rules are in conflict
with the provisions of this Section 5.2, including the provisions concerning the
appointment of arbitrators, the provisions of this Section 5.2 shall prevail.

          (e) Each party to the arbitration shall cooperate with each other party to the arbitration in
making full disclosure of and providing complete access to all information and documents relevant
to the arbitration proceedings and reasonably requested by such other party in connection with such
arbitration proceedings, subject only to any confidentiality obligations binding on such party.

          (f) The arbitrators shall decide any dispute submitted by the parties to the arbitration
tribunal strictly in accordance with the substantive law of New York and shall not apply any other
substantive law.

          (g) Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if
possible, from any court of competent jurisdiction.

          (h) The Parties to this Agreement agree to the consolidation of arbitrations arising out of or
in connection with this Agreement or any of the Transaction Documents in accordance with the
provisions of this Section 5.2.

10

 

     (i) In the event of two or more arbitrations having been commenced arising out of or in
connection with this Agreement or any of the Transaction Documents, the tribunal in the
arbitration first filed (the “Principal Tribunal”) may in its sole discretion, upon the
application of any party to the arbitrations, order that the proceedings under the
Transaction Documents be consolidated before the Principal Tribunal if (1) there are issues
of fact and/or law common to the arbitrations, (2) the interests of justice and efficiency
would be served by such a consolidation, and (3) no prejudice would be caused to any party
in any material respect as a result of such consolidation, whether through undue delay or
otherwise. Such application shall be made as soon as practicable and the party making such
application shall give notice to the other parties to the arbitrations.

     (ii) The Principal Tribunal shall be empowered to (but shall not be obliged to) order
at its discretion, after inviting written (and where desired by the Principal Tribunal oral)
representations from the parties that all or any of such arbitrations shall be consolidated
or heard together and/or that the arbitrations be heard sequentially and shall establish a
procedure accordingly. All parties shall take such steps as are necessary to give effect
and force to any orders of the Principal Tribunal.

     (iii) If the Principal Tribunal makes an order for consolidation, it: (1) shall
thereafter, to the exclusion of other arbitral tribunals, have jurisdiction to resolve all
disputes forming part of the consolidation order; (2) shall order that notice of the
consolidation order and its effect be given immediately to any arbitrators already appointed
in relation to the disputes consolidated under the consolidation order; and (3) may also
give such directions as it considers appropriate (x) to give effect to the consolidation and
make provision for any costs which may result from it (including costs in any arbitration
rendered functus officio under Section 5.2); and (y) to ensure the proper
organization of the arbitration proceedings and that all the issues between the parties are
properly formulated and resolved.

     (iv) Upon the making of the consolidation order, any appointment of arbitrators
relating to arbitrations that have been consolidated by the Principal Tribunal (except for
the appointment of the arbitrators of the Principal Tribunal itself) shall for all purposes
cease to have effect and such arbitrators are deemed to be functus officio, on and from the
date of the consolidation order. Such cessation is without prejudice to (1) the validity of
any acts done or orders made by such arbitrators before termination, (2) such arbitrators’
entitlement to be paid their proper fees and disbursements and (3) the date when any claim
or defense was raised for the purpose of applying any limitation period or any like rule or
provision.

     (v) The Parties hereby waive any objections they may have as to the validity and/or
enforcement of any arbitral awards made by the Principal Tribunal following the
consolidation of disputes or arbitral proceedings in accordance with this Section 5.2
where such objections are based solely on the fact that consolidation of the same has
occurred.

          (i) During the course of the arbitration tribunal’s adjudication of the dispute, this
Agreement shall continue to be performed except with respect to the part in dispute and under
adjudication.

11

 

          (j) The award of the arbitration tribunal shall be final and binding upon the parties, and the
prevailing party may apply to a court of competent jurisdiction for enforcement of such award.

     5.3 Counterparts. This Agreement may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same
instrument. Facsimile and e-mailed copies of signatures shall be deemed to be originals for
purposes of the effectiveness of this Agreement.

     5.4 Notices. Any notice required or permitted pursuant to this Agreement shall be given in
writing and shall be given either personally or by next-day or second-day courier service, fax,
electronic mail or similar means to the address as shown below the signature of such Party on the
signature page of this Agreement (or at such other address as such Party may designate by fifteen
(15) days’ advance written notice to the other parties to this Agreement given in accordance with
this Section 5.4). Where a notice is sent by next-day or second-day courier service,
service of the notice shall be deemed to be effected by properly addressing, pre-paying and sending
by next-day or second-day service through an internationally-recognized courier a letter containing
the notice, with a confirmation of delivery, and to have been effected at the expiration of two
days after the letter containing the same is sent as aforesaid. Where a notice is sent by fax or
electronic mail, service of the notice shall be deemed to be effected by properly addressing, and
sending such notice through a transmitting organization, with a written confirmation of delivery,
and to have been effected on the day the same is sent as aforesaid.

     5.5 Headings and Titles. The headings and titles used in this Agreement are used for
convenience only and are not to be considered in construing or interpreting this Agreement.

     5.6 Expenses. If any action at law or in equity is necessary to enforce or interpret the
terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees,
costs and necessary disbursements in addition to any other relief to which such party may be
entitled.

     5.7 Amendments and Waivers. Any term of this Agreement may be amended and the observance of
any term of this Agreement may be waived (either generally or in a particular instance and either
retroactively or prospectively), only with the written consent of (i) the Company, (ii) holders
holding at least a majority of the then outstanding Ordinary Shares, (iii) holders holding at least
two thirds (2/3) of the then outstanding Series A Preferred Shares, Series B Preferred Shares and
Series C Preferred Shares (voting as a single class), and (iv) the Series A and Series B Lead
Investor, provided, that if any amendment or waiver would have a material and adverse impact on any
individual shareholder of the Company (as compared to other shareholders of the Company) or any
class of Equity Securities of the Company (as compared to any other class of Equity Securities of
the Company), then such amendment or waiver shall require the written consent of such individual
shareholder or of at least two thirds (2/3) of the aggregate voting power of such class of Equity
Securities, as the case may be. Any amendment or waiver effected in accordance with this paragraph
shall be binding upon each party to this Agreement. The Original Right of First Offer and Co-Sale
Agreement has been amended in accordance with Section 5.7 of the Original Right of First Offer and
Co-Sale Agreement; and the Original Right of First Offer and Co-Sale Agreement is hereby amended
and restated and this Amended and Restated Right of First Offer and Co-Sale Agreement replaces the
Original Right of First Offer and Co-Sale Agreement. The Parties agree, notwithstanding any other
provisions of this Agreement, any amendment of the terms of the

12

 

Series A Preferred Shares and/or the Series B Preferred Shares shall not require the consent or
agreement of the holders of the Series C Preferred Shares unless such amendment will adversely
affect the existing rights and obligations of the holders of the Series C Preferred Shares.

     5.8 Additional Investors. Notwithstanding anything to the contrary contained herein, if the
Company issues additional shares of the Company’s Series A Preferred Shares, Series B Preferred
Shares or Series C Preferred Shares after the date hereof, whether pursuant to the Series A Share
Purchase Agreement, the Series B Share Purchase Agreement, the Series C Share Purchase Agreement or
otherwise, any purchaser of such shares of Preferred Shares may become a party to this Agreement by
executing and delivering an additional counterpart signature page to this Agreement as a Series A
Investor, Series B Investor or Series C Investor, and thereafter shall be deemed a Series A
Investor, Series B Investor or Series C Investor for all purposes hereunder. No action or consent
by the Investors shall be required for such joinder to this Agreement by such additional Investor,
so long as such additional Investor has agreed in writing to be bound by all of the obligations as
a Series A Investor, Series B Investor or Series C Investor hereunder.

     5.9 Warrant Holder. If any Warrant Holder exercises its rights under relevant warrants and
consequently acquires any Ordinary Shares of the Company after the date hereof, such Warrant Holder
shall remain a party to this Agreement and be deemed an “Ordinary Shareholder” for all purposes
hereunder immediately upon the issuance of any Ordinary Shares to such Warrant Holder

     5.10 Severability. If a provision of this Agreement is held to be unenforceable under
applicable Laws, such provision shall be excluded from this Agreement and the balance of the
Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in
accordance with its terms.

     5.11 Term. This Agreement shall terminate upon the earlier of the closing of a Qualified IPO
or a Liquidation Event.

     5.12 [Reserved].

     5.13 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of
this Agreement shall inure to the benefit of and be binding upon the respective successors and
assigns of the parties hereto whose rights or obligations hereunder are affected by such terms and
conditions. This Agreement, and the rights and obligations hereunder, shall not be assigned to any
Person other than a Permitted Transferee without the mutual written consent of the parties hereto,
provided that each Investor may assign its rights and obligations to an Affiliate of such Investor
without consent of the other parties under this Agreement. Nothing in this Agreement, express or
implied, is intended to confer upon any party other than the parties hereto or their respective
successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement.

     5.14 Rights Cumulative. Each and all of the various rights, powers and remedies of a Party
hereto will be considered to be cumulative with and in addition to any other rights, powers and
remedies which such Party may have at law or in equity in the event of the breach of any of the
terms of this Agreement. The exercise or partial exercise of any right, power or

13

 

remedy will neither constitute the exclusive election thereof nor the waiver of any other
right, power or remedy available to such Party.

     5.15 No Waiver. Failure to insist upon strict compliance with any of the terms, covenants, or
conditions hereof will not be deemed a waiver of such term, covenant, or condition, nor will any
waiver or relinquishment of, or failure to insist upon strict compliance with, any right, power or
remedy hereunder at any one or more times be deemed a waiver or relinquishment of such right, power
or remedy at any other time or times.

     5.16 No Presumption. The Parties acknowledge that any applicable Law that would require
interpretation of any claimed ambiguities in this Agreement against the Party that drafted it, has
no application and is expressly waived. If any claim is made by a Party relating to any conflict,
omission or ambiguity in the provisions of this Agreement, no presumption or burden of proof or
persuasion will be implied because this Agreement was prepared by or at the request of any Party or
its counsel.

     5.17 No Conflict with Memorandum and Articles. In the event that the provisions of this
Agreement conflict with any provision of the Memorandum and Articles, the provisions of this
Agreement shall prevail and each of the Parties shall do all things and shall take all actions
(including voting shares and procuring directors to vote) as may reasonably be necessary to amend
the Memorandum and Articles in such manner as the Company and the Series A and Series B Lead
Investor are advised by Cayman Islands counsel will remove such conflict and give effect to the
provisions of this Agreement to the fullest extent permitted by law.

     5.18 Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party under this Agreement, upon any breach or default of any other party under
this Agreement, shall impair any such right, power or remedy of such non-breaching or
non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any
waiver of any single breach or default be deemed a waiver of any other breach or default
theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or
character on the part of any party of any breach or default under this Agreement, or any waiver on
the part of any party of any provisions or conditions of this Agreement, must be in writing and
shall be effective only to the extent specifically set forth in such writing. All remedies, either
under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not
alternative.

     5.19 Entire Agreement. This Agreement (including the Exhibits hereto) constitutes the full
and entire understanding and agreement among the parties with regard to the subjects hereof and
thereof, and supersedes all other agreements between or among any of the parties with respect to
the subject matter hereof. After the execution and delivery of this Agreement, to the extent that
there is any conflict between this Agreement and any other agreement, arrangement or understanding
between the Company and any holder of equity securities of the Company, the terms and conditions of
this Agreement shall prevail.

     5.20 Further Instruments and Actions. The Founders and Ordinary Shareholders agree to execute
such further instruments and to take such further action as may reasonably be necessary to carry
out the intent of this Agreement (including voting shares and procuring directors to vote). The
Founders and Ordinary Shareholders agree to cooperate affirmatively

14

 

with the Company and the Investors, to the extent reasonably requested by the Company or any
Investor, to enforce rights and obligations pursuant hereto.

[Signature Pages Follow]

15

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	COMPANY:	CHINA HYDROELECTRIC CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Address:

Facsimile:

 

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 
	FOUNDER:
	 	 
		
	 
	 	 		
	 
	 	 		
	 	 	 
		
	 	 	Address:
	 	

 

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	ORDINARY
SHAREHOLDERS:	VICIS CAPITAL MASTER FUND

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Address:

Facsimile:

	 	 	 	 	 
	 	CHINA HYDRO LLC

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Address:

Facsimile:

 

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 
	SERIES A INVESTOR:

	 	 
	 
	 
	 	 	 

	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Address:

Facsimile:

 

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 
	SERIES B INVESTOR:

	 	 
	 
	 
	 	 	 

	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Address:

Facsimile:

 

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	SERIES C INVESTOR:	Aqua Resources Asia Holdings Limited

 	 
	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Address:

Facsimile:

 

 

          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 
	WARRANT HOLDER:

	 	 
	 
	 
	 	 	 

	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Address:

Facsimile:

 

 

EXHIBIT A(i)

SERIES C INVESTORS

Aqua Resources Asia Holdings Limited

EXHIBIT A(ii)

ORDINARY SHAREHOLDERS

1.     Vicis Capital Master Fund

2.     China Hydro LLC

EXHIBIT A(iii)

SERIES A INVESTORS

1.     
CPI Ballpark Investments Ltd.

2.      Jennison Utility Fund

3.      Vicis Capital Master Fund

4.      Swiss Re Financial Products Corporation

5.      Citigroup Global Markets Inc.

6.      Sandelman Partners Multi-Strategy Master Fund, Ltd.

7.      HSBC GEM Common Fund

8.      HSBC Global Investment Fund — New World Income Fund

9.      Jayhawk Private Equity Co. — Invest Fund, LP

10.    Jayhawk Private Equity Fund, LP

11.    Rosebud Trust — Green

12.    AGE Trust — Green

13.    Kazak II Trust — Green

14.    Tehachapi Pass Trust — Green

15.    NISA Revocable Trust under Agreement Subaccount

16.    Radcliffe SPC, Ltd. (Class A Segregated Portfolio)

17.    Concordia Asia Pacific Multi-Strategy Master Fund LP

 

 

EXHIBIT A(iv)

SERIES B INVESTORS

1.     CPI Ballpark Investments Ltd.

2.     Jennison Utility Fund

3.     Vicis Capital Master Fund

4.     Swiss Re Financial Products Corporation

5.     Blue Ridge Investments, LLC

6.     China Environment Fund III, LP

7.     Abrax

8.     IWU International Ltd.

EXHIBIT A(v)

FOUNDERS

	 	 	 	 	 
	Name	 	ID/Passport Number
	1. John D. Kuhns

	 	156897488
	2. James Tie Li

	 	202580662
	3. Mary Fellows

	 	CT Driver License 164090104

	4. Dr. You-su Lin

	 	E3011189

EXHIBIT A(vi)

WARRANT HOLDERS

1.     China Hydro, LLC

2.     Vicis Capital Master Fund

3.     JMG Triton Offshore Fund, Ltd.

4.     JMG Capital Partners, L.P.

5.     Morgan Joseph & Co. Inc.

 

 

EXHIBIT B

FORM OF JOINDER

	 	 	THIS JOINDER is made on {*}, of {*}
	 
	 	 	BY and AMONG
	 
	(1)	 	THE PERSON WHOSE NAME IS SET OUT IN SCHEDULE 1 (the “New Shareholder”);
	 
	(2)	 	THE PERSON WHOSE NAME IS SET OUT IN SCHEDULE 2 (the “Current Shareholder”); and
	 
	(3)	 	China Hydroelectric Corporation, a company duly incorporated and validly existing under the
Laws of the Cayman Islands (the “Company”).

(collectively the “Parties” and individually a “Party”).

	 	 	WHEREAS:
	 
	(A)	 	An Amended and Restated Right of First Offer and Co-Sale Agreement was entered into as of
{*} among, inter alia, the Current Shareholder, the Company and other parties thereto (the
“ROFO Agreement”).
	 
	(B)	 	The Current Shareholder proposes to transfer {*} {*} shares, par value US$0.001 per share, of
the Company (the “Shares”) to the New Shareholder.
	 
	 	 	NOW THIS JOINDER WITNESSES as follows:

	1.	 	All capitalized terms used but not defined herein shall have the meanings set forth in the
ROFO Agreement.
	 
	2.	 	The New Shareholder hereby (i) acknowledges receipt of a copy of the ROFO Agreement, (ii)
accedes to and ratifies the ROFO Agreement, and (iii) covenants and agrees with the Current
Shareholder and the Company to be bound by the terms of the ROFO Agreement as if it had been a
party thereto from the outset and to duly and punctually perform and discharge all liabilities
and obligations whatsoever from time to time to be performed or discharged by the New
Shareholder under or by virtue of the ROFO Agreement in all respects as if named as a [Series
A Investor][Series B Investor][Series C Investor] therein in place of the Current Shareholder
with respect to the Shares.
	 
	3.	 	The Current Shareholder and the Company covenants and agrees that the New Shareholder shall
be entitled to all of the benefits of the terms and conditions of the ROFO Agreement enjoyed
by the Current Shareholder by virtue of the Current Shareholder’s ownership of the Shares to
the intent and effect that the New Shareholder shall be deemed, with effect from the date on
which the New Shareholder is registered as a shareholder of the Company, to be a party to the
ROFO Agreement in all respects as if named as a party therein.

 

 

	4.	 	The Current Shareholder hereby represents, warrants and undertakes to the Company that the
information set out in the Recitals above is true and accurate. Each Current Shareholder and
New Shareholder further acknowledges, confirms and agrees that:

	 	(a)	 	the Shares are being transferred to the New Shareholder by virtue of the New
Shareholder being a Permitted Transferee of the Current Shareholder;
	 
	 	(b)	 	in the event the aforesaid condition ceases to be true, then the New
Shareholder shall promptly sell, and the Current Shareholder shall promptly purchase,
for aggregate consideration of US$1.00, all of the Shares transferred by the Current
Shareholder to the New Shareholder.

	5.	 	The Current Shareholder hereby irrevocably and unconditionally agrees, warrants and
undertakes that he shall remain a party of the ROFO Agreement and that all provisions of the
ROFO Agreement applicable to the Shares shall, from and after the date hereof, apply equally
to all of the Equity Securities held by the Current Shareholder in each New Shareholder.
	 
	6.	 	The Current Shareholder hereby irrevocably and unconditionally agrees, warrants and
undertakes that he shall procure the New Shareholder to observe and comply with the terms of
the ROFO Agreement.
	 
	7.	 	Each of the Parties hereby agrees that this Joinder shall hereafter be read and construed in
conjunction and as one document with the ROFO Agreement and references in the ROFO Agreement
to “the Agreement” or “this Agreement”, and references in all other instruments and documents
executed thereunder or pursuant thereto to the ROFO Agreement, shall for all purposes refer to
the ROFO Agreement incorporating and as supplemented by this Joinder.
	 
	8.	 	This Joinder shall be governed by and construed in accordance with the laws of the State of
New York. In relation to any legal action or proceedings arising out of or in connection with
this Joinder, each of the parties hereto hereby irrevocably submits to arbitration in Hong
Kong in accordance with Section 5.2 of the ROFO Agreement.

SCHEDULE 1

NEW SHAREHOLDER

{*}

SCHEDULE 2

CURRENT SHAREHOLDER

{*}

EXECUTION PAGE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]